Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Vascular Surgery

  Free Subscription


Articles published in Catheter Cardiovasc Interv

Retrieve available abstracts of 394 articles:
HTML format
Text format



Single Articles


    April 2017
  1. PATEL A, Nazif T, Stone GW, Ali ZA, et al
    Intraluminal bioresorbable vascular scaffold dismantling with aneurysm formation leading to very late thrombosis.
    Catheter Cardiovasc Interv. 2017;89:876-879.
    PubMed     Text format     Abstract available


  2. AZZALINI L, Dautov R, Ojeda S, Serra A, et al
    Long-term outcomes of rotational atherectomy for the percutaneous treatment of chronic total occlusions.
    Catheter Cardiovasc Interv. 2017;89:820-828.
    PubMed     Text format     Abstract available


  3. PALENA LM, Diaz-Sandoval LJ, Sultato E, Brigato C, et al
    Feasibility and 1-Year outcomes of subintimal revascularization with supera(R) stenting of long femoropopliteal occlusions in critical limb ischemia: The "Supersub" Study.
    Catheter Cardiovasc Interv. 2017;89:910-920.
    PubMed     Text format     Abstract available


  4. LEE MS, Lee AC, Shlofmitz RA, Martinsen BJ, et al
    ORBIT II sub-analysis: Impact of impaired renal function following treatment of severely calcified coronary lesions with the Orbital Atherectomy System.
    Catheter Cardiovasc Interv. 2017;89:841-848.
    PubMed     Text format     Abstract available


  5. ORTEGA-PAZ L, Capodanno D, Giacchi G, Gori T, et al
    Impact of overlapping on 1-year clinical outcomes in patients undergoing everolimus-eluting bioresorbable scaffolds implantation in routine clinical practice: Insights from the European multicenter GHOST-EU registry.
    Catheter Cardiovasc Interv. 2017;89:812-818.
    PubMed     Text format     Abstract available


  6. HUDED CP, Youmans QR, Sweis RN, Ricciardi MJ, et al
    The impact of operator experience during institutional adoption of trans-radial cardiac catheterization.
    Catheter Cardiovasc Interv. 2017;89:860-865.
    PubMed     Text format     Abstract available


  7. SAKAKURA K, Funayama H, Taniguchi Y, Tsurumaki Y, et al
    The incidence of slow flow after rotational atherectomy of calcified coronary arteries: A randomized study of low speed versus high speed.
    Catheter Cardiovasc Interv. 2017;89:832-840.
    PubMed     Text format     Abstract available


  8. HABARA M, Tsuchikane E, Nasu K, Kinoshita Y, et al
    The first clinical experience with a novel directional coronary atherectomy catheter: Preliminary Japanese multicenter experience.
    Catheter Cardiovasc Interv. 2017;89:880-887.
    PubMed     Text format     Abstract available


  9. DAUTOV R, Nguyen CM, Rinfret S
    Stent luxation: Possible complication of subadventitial stenting in coronary chronic total occlusion revascularization.
    Catheter Cardiovasc Interv. 2017;89:872-875.
    PubMed     Text format     Abstract available


  10. SANDOVAL Y, Brilakis ES
    The role of rotational atherectomy in contemporary chronic total occlusion percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2017;89:829-831.
    PubMed     Text format     Abstract available


  11. HILLEGASS WB
    The many radial access learning curves.
    Catheter Cardiovasc Interv. 2017;89:865-866.
    PubMed     Text format     Abstract available


  12. BELARDI JA, Albertal M
    Overlapping bioresorbable scaffolds seems safe for now.
    Catheter Cardiovasc Interv. 2017;89:818-819.
    PubMed     Text format     Abstract available


    March 2017
  13. CHE W, Dong H, Jiang X, Peng M, et al
    Subclavian artery stenting for coronary-subclavian steal syndrome.
    Catheter Cardiovasc Interv. 2017;89.
    PubMed     Text format     Abstract available


  14. JIA H, Hu S, Liu H, Zhu Y, et al
    Chronic total occlusion is associated with a higher incidence of malapposition and uncovered stent struts: OCT findings at 6 months following DES implantation.
    Catheter Cardiovasc Interv. 2017;89.
    PubMed     Text format     Abstract available


  15. QI J, Li Y, Li J, Jing Q, et al
    Safety and efficacy of 6-month versus 12-month dual antiplatelet therapy in patients after implantation of multiple biodegradable polymer-coated sirolimus-eluting coronary stents: Insight from the I-LOVE-IT 2 trial.
    Catheter Cardiovasc Interv. 2017;89.
    PubMed     Text format     Abstract available


  16. HU S, Wang C, Zhe C, Zhu Y, et al
    Plaque erosion delays vascular healing after drug eluting stent implantation in patients with acute coronary syndrome: An In Vivo Optical Coherence Tomography Study.
    Catheter Cardiovasc Interv. 2017;89.
    PubMed     Text format     Abstract available


  17. HE C, Ma YL, Wang CS, Song Y, et al
    Effect of coronary dominance on 2-year outcomes after percutaneous coronary intervention in patients with acute coronary syndrome.
    Catheter Cardiovasc Interv. 2017;89.
    PubMed     Text format     Abstract available


  18. GAO L, Wang Y, Liu Y, Cao F, et al
    Long-term clinical outcomes of successful revascularization with drug-eluting stents for chronic total occlusions: A systematic review and meta-analysis.
    Catheter Cardiovasc Interv. 2017;89.
    PubMed     Text format     Abstract available


  19. QIU M, Li Y, Li J, Xu K, et al
    Impact of six versus 12 months of dual antiplatelet therapy in patients with drug-eluting stent implantation after risk stratification with the residual SYNTAX score: Results from a secondary analysis of the I-LOVE-IT 2 trial.
    Catheter Cardiovasc Interv. 2017;89.
    PubMed     Text format     Abstract available


  20. DONG H, Peng M, Jiang X, Che W, et al
    Endovascular therapy for Angio-sealTM -related acute limb ischemia: Perioperative and long-term results.
    Catheter Cardiovasc Interv. 2017;89.
    PubMed     Text format     Abstract available


  21. WANG G, Wang H, Xu B, Yang Y, et al
    Efficacy and safety of a biodegradable polymer Cobalt-Chromium sirolimus-eluting stent (EXCEL2) in treating de novo coronary artery disease: A pooled analysis of the CREDIT II and CREDIT III trials.
    Catheter Cardiovasc Interv. 2017;89.
    PubMed     Text format     Abstract available


  22. XU B, Bettinger N, Guan C, Redfors B, et al
    Impact of completeness of revascularization in complex coronary artery disease as measured with the SYNTAX revascularization index: An SEEDS Substudy.
    Catheter Cardiovasc Interv. 2017;89.
    PubMed     Text format     Abstract available


  23. BLOOMER TL, El-Hayek GE, McDaniel MC, Sandvall BC, et al
    Safety of catheter-directed thrombolysis for massive and submassive pulmonary embolism: Results of a multicenter registry and meta-analysis.
    Catheter Cardiovasc Interv. 2017;89:754-760.
    PubMed     Text format     Abstract available


  24. LATINI RA, Buccheri D, Cortese B
    First reported use of drug-coated balloon for bioresorbable in-scaffold restenosis.
    Catheter Cardiovasc Interv. 2017;89:676-678.
    PubMed     Text format     Abstract available


  25. BELARDI JA, Albertal M
    Non-cardiac surgery after PCI: Watch out for complex lesions.
    Catheter Cardiovasc Interv. 2017;89:627-628.
    PubMed     Text format    


  26. AZZALINI L, Brilakis ES
    Ipsilateral vs. contralateral vs. no collateral (antegrade only) chronic total occlusion percutaneous coronary interventions: What is the right choice for your practice?
    Catheter Cardiovasc Interv. 2017;89:656-657.
    PubMed     Text format    


  27. PALMERINI T
    Myocardial revascularization with percutaneous coronary intervention: To complete or not to complete?
    Catheter Cardiovasc Interv. 2017;89.
    PubMed     Text format    


    February 2017
  28. COOLS B, Rega F, Gewillig M
    Transhepatic implant of a trimmed Melody valved stent in tricuspid position in a 1-year-old infant.
    Catheter Cardiovasc Interv. 2017;89:E84-E89.
    PubMed     Text format     Abstract available


  29. BABUNASHVILI AM, Pancholy SB, Kartashov DS
    New technique for treatment of postcatheterization radial artery pseudoaneurysm.
    Catheter Cardiovasc Interv. 2017;89:393-398.
    PubMed     Text format     Abstract available


  30. ORTIZ D, Singh M, Jahangir A, Allaqaband S, et al
    Bivalirudin versus unfractionated heparin during peripheral vascular interventions: A Propensity-matched Study.
    Catheter Cardiovasc Interv. 2017;89:408-413.
    PubMed     Text format     Abstract available


  31. BUTERA G, Piazza L, Heles M
    PFO "angioplasty": The preparation of a very stiff and long tunnel for device closure.
    Catheter Cardiovasc Interv. 2017;89:480-483.
    PubMed     Text format     Abstract available


  32. HEE L, Terluk A, Thomas L, Hopkins A, et al
    Late clinical outcomes for SeQuent please paclitaxel-coated balloons in PCI of instent restenosis and de novo lesions: A single-center, real world registry.
    Catheter Cardiovasc Interv. 2017;89:375-382.
    PubMed     Text format     Abstract available


  33. ZAHR F, Cigarroa JE
    Revascularization after coronary artery bypass grafting; Another episode in a long saga.
    Catheter Cardiovasc Interv. 2017;89:349-350.
    PubMed     Text format    


  34. AZZALINI L, Jolicoeur EM
    The wise radialist's guide to optimal transfemoral access: Selection, performance, and troubleshooting.
    Catheter Cardiovasc Interv. 2017;89:399-407.
    PubMed     Text format     Abstract available


  35. ZHANG D, Li Y, Yin D, He Y, et al
    Risk stratification of periprocedural myocardial infarction after percutaneous coronary intervention: Analysis based on the SCAI definition.
    Catheter Cardiovasc Interv. 2017 Feb 13. doi: 10.1002/ccd.26939.
    PubMed     Text format     Abstract available


  36. RAVAT H, Garekar S, Changela V
    Left main coronary angioplasty of a 9-year-old child with bioresorable vascular scaffold.
    Catheter Cardiovasc Interv. 2017 Feb 10. doi: 10.1002/ccd.26896.
    PubMed     Text format     Abstract available


  37. POTERUCHA JT, Taggart NW, Johnson JN, Cannon BC, et al
    Intravascular and hybrid intraoperative stent placement for baffle obstruction in transposition of the great arteries after atrial switch.
    Catheter Cardiovasc Interv. 2017;89:306-314.
    PubMed     Text format     Abstract available


  38. KLEIN LW, Harjai KJ, Resnic F, Weintraub WS, et al
    2016 Revision of the SCAI position statement on public reporting.
    Catheter Cardiovasc Interv. 2017;89:269-279.
    PubMed     Text format    


  39. VAN DEN HOVEN AT, Duijnhouwer AL, Eicken A, Aboulhosn J, et al
    Adverse outcome of coarctation stenting in patients with Turner syndrome.
    Catheter Cardiovasc Interv. 2017;89:280-287.
    PubMed     Text format     Abstract available


  40. LIGON RA, Petit CJ
    Not that atretic: Use of an atretic femoral vein for transcatheter pulmonary valve implantation.
    Catheter Cardiovasc Interv. 2017;89:321-323.
    PubMed     Text format     Abstract available


  41. GARBO R, Oreglia JA, Gasparini GL
    The Balloon-Microcatheter technique for treatment of coronary artery perforations.
    Catheter Cardiovasc Interv. 2017;89:E75-E83.
    PubMed     Text format     Abstract available


  42. SHAH AH, Horlick EM, Eicken A, Asnes JD, et al
    Transcatheter valve implantation for right atrium-to-right ventricle conduit obstruction or regurgitation after modified Bjork-fontan procedure.
    Catheter Cardiovasc Interv. 2017;89:298-305.
    PubMed     Text format     Abstract available


  43. SAWAYA FJ, Morice MC, Spaziano M, Mehran R, et al
    Short-versus long-term Dual Antiplatelet therapy after drug-eluting stent implantation in women versus men: A sex-specific patient-level pooled-analysis of six randomized trials.
    Catheter Cardiovasc Interv. 2017;89:178-189.
    PubMed     Text format     Abstract available


  44. SHEMISA K, Karatasakis A, Brilakis ES
    Management of guidewire-induced distal coronary perforation using autologous fat particles versus coil embolization.
    Catheter Cardiovasc Interv. 2017;89:253-258.
    PubMed     Text format     Abstract available


    January 2017
  45. GUAN C, Xu B, Qiao S, Qin L, et al
    Comparison of two biodegradable-polymer-based sirolimus-eluting stents with varying elution and absorption kinetics in patients with acute myocardial infarction: A subgroup analysis of the PANDA III trial.
    Catheter Cardiovasc Interv. 2017 Jan 21. doi: 10.1002/ccd.26918.
    PubMed     Text format     Abstract available


  46. TENEKECIOGLU E, Albuquerque FN, Sotomi Y, Zeng Y, et al
    Intracoronary optical coherence tomography: Clinical and research applications and intravascular imaging software overview.
    Catheter Cardiovasc Interv. 2017 Jan 21. doi: 10.1002/ccd.26920.
    PubMed     Text format     Abstract available


  47. BROWN ED, Blankenship JC
    A mechanism for stroke complicating thrombus aspiration.
    Catheter Cardiovasc Interv. 2017;89:93-96.
    PubMed     Text format     Abstract available


  48. XHEPA E, Tada T, Kufner S, Ndrepepa G, et al
    Long-term prognostic value of risk scores after drug-eluting stent implantation for unprotected left main coronary artery: A pooled analysis of the ISAR-LEFT-MAIN and ISAR-LEFT-MAIN 2 randomized clinical trials.
    Catheter Cardiovasc Interv. 2017;89:1-10.
    PubMed     Text format     Abstract available


  49. KAWAMOTO H, Takagi K, Chieffo A, Ruparelia N, et al
    Long-term outcomes following mini-crush versus culotte stenting for the treatment of unprotected left main disease: Insights from the milan and New-Tokyo (MITO) registry.
    Catheter Cardiovasc Interv. 2017;89:13-24.
    PubMed     Text format     Abstract available


  50. NAGANUMA T, Colombo A, Lesiak M, Capodanno D, et al
    Bioresorbable vascular scaffold use for coronary bifurcation lesions: A substudy from GHOST EU registry.
    Catheter Cardiovasc Interv. 2017;89:47-56.
    PubMed     Text format     Abstract available


  51. BOUDJEMLINE Y
    Covidien micro vascular plug in congenital heart diseases and vascular anomalies: A new kid on the block for premature babies and older patients.
    Catheter Cardiovasc Interv. 2017;89:114-119.
    PubMed     Text format     Abstract available


  52. FERRARO G, Marini D, Agnoletti G
    Off-label use of the amplatzer ductal occluder II additional size for percutaneous treatment of acute aortic occlusion in a baby.
    Catheter Cardiovasc Interv. 2017;89:E26-E29.
    PubMed     Text format     Abstract available


  53. BUTERA G, Lovin N, Basile DP
    How to deal with atrial septal defect closure from right internal jugular vein: Role of venous-arterial circuit for sizing and over-the-wire device implantation.
    Catheter Cardiovasc Interv. 2017;89:120-123.
    PubMed     Text format     Abstract available


  54. URIBE CE, Zuniga M, Madrid C
    Mechanical thrombectomy using the Solitaire stent in a left main coronary artery: A novel approach to coronary thrombus retrieval.
    Catheter Cardiovasc Interv. 2017;89:71-77.
    PubMed     Text format     Abstract available


  55. BELARDI JA, Albertal M
    Double-stenting in distal left main lesions: Let's crush.
    Catheter Cardiovasc Interv. 2017;89:24-25.
    PubMed     Text format     Abstract available


  56. CHATTERJEE A, Hillegass WB
    Unprotected Left Main Disease and Percutaneous Intervention: A Prototype for Precision Medicine.
    Catheter Cardiovasc Interv. 2017;89:11-12.
    PubMed     Text format     Abstract available


    December 2016
  57. DING L, Pockett C, Moore J, El-Said H, et al
    Long sheath use in femoral artery catheterizations in infants <15 kg is associated with a higher thrombosis rate: Proposed Protocol for Detection and Management.
    Catheter Cardiovasc Interv. 2016;88:1108-1112.
    PubMed     Text format     Abstract available


  58. KRAJCER Z, Ramaiah VG, Huetter M, Miller LE, et al
    Fast-track endovascular aortic repair: Interim report from the prospective LIFE registry.
    Catheter Cardiovasc Interv. 2016;88:1118-1123.
    PubMed     Text format     Abstract available


  59. NGUYEN-TRONG PJ, Martinez Parachini JR, Resendes E, Karatasakis A, et al
    Procedural outcomes with use of the flash ostial system in aorto-coronary ostial lesions.
    Catheter Cardiovasc Interv. 2016;88:1067-1074.
    PubMed     Text format     Abstract available


  60. BOE BA, Rectenwald JE, Bocks ML
    Severely regurgitant left ventricle to ascending aorta conduit in a failing fontan patient treated with a vascular endograft and melody transcatheter pulmonary valve via hybrid approach.
    Catheter Cardiovasc Interv. 2016;88:1113-1117.
    PubMed     Text format     Abstract available


  61. LYEN SM, Rodrigues JC, Manghat NE, Hamilton MC, et al
    Endovascular closure of thoracic aortic pseudoaneurysms: A combined device occlusion and coil embolization technique in patients unsuitable for surgery or stenting.
    Catheter Cardiovasc Interv. 2016;88:1155-1169.
    PubMed     Text format     Abstract available


  62. SEGREST JH, Hillegass WB
    Radial Access Optimization in the Nascent Post-Adoption Era.
    Catheter Cardiovasc Interv. 2016;88:1044-1045.
    PubMed     Text format     Abstract available


  63. BROWN BJ, Abbott JD
    A helping hand: GuideLiner use to facilitate stent delivery.
    Catheter Cardiovasc Interv. 2016;88:1065-1066.
    PubMed     Text format     Abstract available


    November 2016
  64. DANEK BA, Brilakis ES
    Serenity, courage, and wisdom: The keys to successful coronary calcification treatment.
    Catheter Cardiovasc Interv. 2016;88:897-898.
    PubMed     Text format    


  65. SAFIAN RD
    Provisional rotablator for calcified lesions: The Russian roulette of PCI.
    Catheter Cardiovasc Interv. 2016;88:889-890.
    PubMed     Text format    


  66. REILLY J
    You can't get there from here.
    Catheter Cardiovasc Interv. 2016;88:932-933.
    PubMed     Text format    


  67. LEESAR MA
    Bioresorbable vascular scaffolds in coronary bifurcation lesions: The next frontiers?
    Catheter Cardiovasc Interv. 2016;88:870-871.
    PubMed     Text format    


  68. HERBERT CE, Veeram Reddy S, Welch TR, Wang J, et al
    Bench and initial preclinical results of a novel 8 mm diameter double opposed helical biodegradable stent.
    Catheter Cardiovasc Interv. 2016;88:902-911.
    PubMed     Text format     Abstract available


  69. RUZSA Z, Toth K, Nemes B, Edes IF, et al
    Transradial and transulnar access for iliac artery interventions using sheathless guiding systems: A feasibility study.
    Catheter Cardiovasc Interv. 2016;88:923-931.
    PubMed     Text format     Abstract available


  70. TANAKA A, Jabbour RJ, Kawamoto H, Mangieri A, et al
    Preliminary Report of Clinical Outcomes After Single Crossover Bioresorbable Scaffold Implantation Without Routine Side Branch Strut Dilation.
    Catheter Cardiovasc Interv. 2016;88:865-870.
    PubMed     Text format     Abstract available


  71. TANAKA A, Latib A, Kawamoto H, Jabbour RJ, et al
    Clinical outcomes following bifurcation double-stenting with bioresorbable scaffolds.
    Catheter Cardiovasc Interv. 2016;88:854-862.
    PubMed     Text format     Abstract available


  72. TROBS M, Achenbach S, Rother J, Klinghammer L, et al
    Bioresorbable vascular scaffold thrombosis in a consecutive cohort of 550 patients.
    Catheter Cardiovasc Interv. 2016;88:872-880.
    PubMed     Text format     Abstract available


  73. IANNACCONE M, Barbero U, D'ascenzo F, Latib A, et al
    Rotational atherectomy in very long lesions: Results for the ROTATE registry.
    Catheter Cardiovasc Interv. 2016;88:E164-E172.
    PubMed     Text format     Abstract available


  74. KOIFMAN E, Gaglia MA Jr, Escarcega RO, Bernardo NL, et al
    Comparison of transradial and transfemoral access in patients undergoing percutaneous coronary intervention for complex coronary lesions.
    Catheter Cardiovasc Interv. 2016 Nov 10. doi: 10.1002/ccd.26669.
    PubMed     Text format     Abstract available


  75. SAFIAN RD
    Carotid artery stenting: Avoiding the perfect storm.
    Catheter Cardiovasc Interv. 2016;88:830-831.
    PubMed     Text format    


  76. BLANKENSHIP JC
    Thrombus aspiration: Suck it up and keep looking for a niche.
    Catheter Cardiovasc Interv. 2016;88:725-726.
    PubMed     Text format    


  77. SETO AH, Kern MJ
    Does the AToMIC trial explode concerns of contrast coagulopathy?
    Catheter Cardiovasc Interv. 2016;88:738-739.
    PubMed     Text format    


  78. MCELHINNEY DB
    Hybrid transcatheter pulmonary valve replacement: Moving into the mainstream?
    Catheter Cardiovasc Interv. 2016;88:811-813.
    PubMed     Text format    


  79. FARHAN S, Mehran R
    STEMI with multivessel disease: An ongoing battle for the optimal treatment strategy.
    Catheter Cardiovasc Interv. 2016;88:707-708.
    PubMed     Text format    


  80. ECHEVERRIA A, Krajcer Z
    Long-term outcomes of the SMART stent in femoro-popliteal disease in TASC A/B lesions and TASC C/D lesions.
    Catheter Cardiovasc Interv. 2016;88:841-842.
    PubMed     Text format    


  81. BUTMAN SM
    The newly occluded ectatic vessel: Not an ecstatic time.
    Catheter Cardiovasc Interv. 2016;88:753-754.
    PubMed     Text format    


  82. SHARMA R, Henry TD
    Come one, come all...the sooner the better!
    Catheter Cardiovasc Interv. 2016;88:689-690.
    PubMed     Text format    


  83. RIZIK DG, Hermiller JB, Kereiakes DJ
    Bioresorbable vascular scaffolds for the treatment of coronary artery disease: Clinical outcomes from randomized controlled trials.
    Catheter Cardiovasc Interv. 2016;88.
    PubMed     Text format     Abstract available


  84. CHAMIE D, Garcia-Garcia H, Costa RA, Onuma Y, et al
    Role of invasive imaging in acute and long-term assessment of bioresorbable scaffold technology.
    Catheter Cardiovasc Interv. 2016;88.
    PubMed     Text format     Abstract available


  85. PERKINS LE, Kossuth MB, Fox JC, Rapoza RJ, et al
    Paving the way to a bioresorbable technology: Development of the absorb BRS program.
    Catheter Cardiovasc Interv. 2016;88.
    PubMed     Text format     Abstract available


  86. TAMBURINO C, Capranzano P, Francaviglia B, Ina Tamburino C, et al
    Update on clinical evidence (Part II): A summary of the main post market studies.
    Catheter Cardiovasc Interv. 2016;88.
    PubMed     Text format     Abstract available


  87. TANAKA A, Jabbour RJ, Latib A, Colombo A, et al
    Bioresorbable vascular scaffolds: From patient selection to optimal scaffold implantation; tips and tricks to minimize device failure.
    Catheter Cardiovasc Interv. 2016;88.
    PubMed     Text format     Abstract available


  88. ABIZAID A, Ribamar Costa J Jr
    The unmet needs: How future technologies will address current limitations of bioresorbable scaffold technology.
    Catheter Cardiovasc Interv. 2016;88.
    PubMed     Text format     Abstract available


  89. BADINGS EA, Remkes WS, The SH, Dambrink JE, et al
    Early or late intervention in patients with transient ST-segment elevation acute coronary syndrome: Subgroup analysis of the ELISA-3 trial.
    Catheter Cardiovasc Interv. 2016;88:755-764.
    PubMed     Text format     Abstract available


  90. SOSNOWSKI C, Matella T, Fogg L, Ilbawi M, et al
    Hybrid pulmonary artery plication followed by transcatheter pulmonary valve replacement: Comparison with surgical PVR.
    Catheter Cardiovasc Interv. 2016;88:804-810.
    PubMed     Text format     Abstract available


  91. MATSUMI J, Tobita K, Shishido K, Mizuno S, et al
    Long-term outcomes of SMART stent implantation in patients with femoro-popliteal disease.
    Catheter Cardiovasc Interv. 2016;88:832-841.
    PubMed     Text format     Abstract available


  92. MELLER SM, Salim Al-Damluji M, Gutierrez A, Stilp E, et al
    Carotid stenting versus endarterectomy for the treatment of carotid artery stenosis: Contemporary results from a large single center study.
    Catheter Cardiovasc Interv. 2016;88:822-830.
    PubMed     Text format     Abstract available


  93. THEODOROPOULOS K, Mennuni MG, Dangas GD, Meelu OA, et al
    Resistant in-stent restenosis in the drug eluting stent era.
    Catheter Cardiovasc Interv. 2016;88:777-785.
    PubMed     Text format     Abstract available


    October 2016
  94. EFTYCHIOU C, Barmby DS, Wilson SJ, Ubaid S, et al
    Cardiovascular Outcomes Following Rotational Atherectomy: A UK Multicentre Experience.
    Catheter Cardiovasc Interv. 2016;88:546-553.
    PubMed     Text format     Abstract available


  95. YETGIN T, van Kranenburg M, Ten Cate T, Duncker DJ, et al
    Ischemic Postconditioning After Routine Thrombus Aspiration During Primary Percutaneous Coronary Intervention: Rationale and Design of the POstconditioning Rotterdam Trial.
    Catheter Cardiovasc Interv. 2016;88:508-514.
    PubMed     Text format     Abstract available


  96. ARORA S, Panaich SS, Patel N, Patel NJ, et al
    Impact of Glycoprotein IIb/IIIa Inhibitors Use on Outcomes After Lower Extremity Endovascular Interventions From Nationwide Inpatient Sample (2006-2011).
    Catheter Cardiovasc Interv. 2016;88:605-616.
    PubMed     Text format     Abstract available


  97. BASAVARAJAIAH S, Naganuma T, Latib A, Sticchi A, et al
    Treatment of drug-eluting stent restenosis: Comparison between drug-eluting balloon versus second-generation drug-eluting stents from a retrospective observational study.
    Catheter Cardiovasc Interv. 2016;88:522-528.
    PubMed     Text format     Abstract available


  98. TIAN W, Mahmoudi M, Lhermusier T, Kiramijyan S, et al
    The influence of advancing age on implantation of drug-eluting stents.
    Catheter Cardiovasc Interv. 2016;88:516-521.
    PubMed     Text format     Abstract available


  99. SINGH S, Singh N, Gulati GS, Ramakrishnan S, et al
    Dual-Source Computed Tomography for Chronic Total Occlusion of Coronary Arteries.
    Catheter Cardiovasc Interv. 2016;88:E117-E125.
    PubMed     Text format     Abstract available


  100. BELARDI JA, Albertal M
    Ischemic Postconditioning: Not Giving Up Yet.
    Catheter Cardiovasc Interv. 2016;88:514-515.
    PubMed     Text format     Abstract available


  101. SAFIAN RD
    The Third Rail of Interventional Cardiology: Revascularization of Non-Infarct-Related Arteries During Primary PCI.
    Catheter Cardiovasc Interv. 2016;88:506-507.
    PubMed     Text format    


  102. HEUSER RR
    ACS Treatment Continues to Improve: But Price Matters.
    Catheter Cardiovasc Interv. 2016;88:544-545.
    PubMed     Text format     Abstract available


    September 2016
  103. VERMA S, Burkhoff D, O'Neill WW
    Avoiding hemodynamic collapse during high-risk percutaneous coronary intervention: Advanced hemodynamics of impella support.
    Catheter Cardiovasc Interv. 2016 Sep 23. doi: 10.1002/ccd.26795.
    PubMed     Text format     Abstract available


  104. A MCCROSSAN B, O'Callaghan B, P Walsh K
    Stent implantation to relieve native obstructed left partial anomalous pulmonary venous connections.
    Catheter Cardiovasc Interv. 2016;88:452-5.
    PubMed     Text format     Abstract available


  105. DILETTI R, Tchetche D, Barbato E, Latib A, et al
    Bioresorbable scaffolds for treatment of coronary bifurcation lesions: Critical appraisal and future perspectives.
    Catheter Cardiovasc Interv. 2016;88:397-406.
    PubMed     Text format     Abstract available


  106. GENEREUX P, Bettinger N, Redfors B, Lee AC, et al
    Two-year outcomes after treatment of severely calcified coronary lesions with the orbital atherectomy system and the impact of stent types: Insight from the ORBIT II trial.
    Catheter Cardiovasc Interv. 2016;88:369-77.
    PubMed     Text format     Abstract available


  107. MALEKZADEH-MILANI S, Jalal Z, Tamisier D, Boudjemline Y, et al
    Dilatable pulmonary artery band: Safety and efficacy of balloon dilatation.
    Catheter Cardiovasc Interv. 2016;88:446-51.
    PubMed     Text format     Abstract available


  108. SOTOMI Y, Serruys PW
    Promising, but still a matter of debate.
    Catheter Cardiovasc Interv. 2016;88:378-9.
    PubMed     Text format     Abstract available


  109. BELARDI JA, Albertal M
    To achieve, or not to achieve complete revascularization.
    Catheter Cardiovasc Interv. 2016;88:338-9.
    PubMed     Text format     Abstract available


  110. GOLDSTEIN JA
    Stenting precision: "Image small, miss small".
    Catheter Cardiovasc Interv. 2016;88:348-9.
    PubMed     Text format     Abstract available


  111. HEUSER RR
    Coronary perforation: The solution is right on the table.
    Catheter Cardiovasc Interv. 2016;88:494.
    PubMed     Text format    


  112. GEORGE S, Cotton J, Wrigley B
    Rebuttal: Coronary perforation: The solution is right on the table.
    Catheter Cardiovasc Interv. 2016;88:495.
    PubMed     Text format    


    August 2016
  113. ROGGEN M, Dubois C, Gewillig M
    Coronary artery stenting in a patient with progeria.
    Catheter Cardiovasc Interv. 2016 Aug 27. doi: 10.1002/ccd.26730.
    PubMed     Text format     Abstract available


  114. KORABATHINA R, Levine JC, Coppola JT
    Innovative use of a guideliner catheter to assist in snare retrieval of an entrapped kinked guide catheter during transradial coronary intervention.
    Catheter Cardiovasc Interv. 2016 Aug 27. doi: 10.1002/ccd.26774.
    PubMed     Text format     Abstract available


  115. MOTTILLO S, Filion KB, Joseph L, Eisenberg MJ, et al
    Defining optimal activated clotting time for percutaneous coronary intervention: A systematic review and Bayesian meta-regression.
    Catheter Cardiovasc Interv. 2016 Aug 22. doi: 10.1002/ccd.26652.
    PubMed     Text format     Abstract available


  116. KAWAMOTO H, Ruparelia N, Latib A, Miyazaki T, et al
    Expansion in calcific lesions and overall clinical outcomes following bioresorbable scaffold implantation optimized with intravascular ultrasound.
    Catheter Cardiovasc Interv. 2016 Aug 22. doi: 10.1002/ccd.26725.
    PubMed     Text format     Abstract available


  117. ALEXANDER J, Yohannan T, Abutineh I, Agrawal V, et al
    Ultrasound-guided femoral arterial access in pediatric cardiac catheterizations: A prospective evaluation of the prevalence, risk factors, and mechanism for acute loss of arterial pulse.
    Catheter Cardiovasc Interv. 2016 Aug 18. doi: 10.1002/ccd.26702.
    PubMed     Text format     Abstract available


  118. YANG X, Tamez H, Lai C, Ho K, et al
    Type 4a myocardial infarction: Incidence, risk factors, and long-term outcomes.
    Catheter Cardiovasc Interv. 2016 Aug 18. doi: 10.1002/ccd.26688.
    PubMed     Text format     Abstract available


  119. MIKI K, Fujii K, Kawasaki D, Shibuya M, et al
    Impact of analysis interval size on the quality of optical frequency domain imaging assessments of stent implantation for lesions of the superficial femoral artery.
    Catheter Cardiovasc Interv. 2016 Aug 12. doi: 10.1002/ccd.26673.
    PubMed     Text format     Abstract available


  120. BRADLEY EA, Berman D, Daniels CJ
    First implantable hemodynamic monitoring device placement in single ventricle fontan anatomy.
    Catheter Cardiovasc Interv. 2016;88:248-52.
    PubMed     Text format     Abstract available


  121. NOONAN P, Kudumula V, Anderson B, Ramchandani B, et al
    Stenting of the left pulmonary artery after palliation of hypoplastic left heart syndrome.
    Catheter Cardiovasc Interv. 2016;88:225-32.
    PubMed     Text format     Abstract available


  122. VOGEL B, Mehran R
    Arterial hypertension: A neglected risk for bleeding.
    Catheter Cardiovasc Interv. 2016;88:191-2.
    PubMed     Text format     Abstract available


  123. BELARDI JA, Albertal M
    Optimal anticoagulation prior to cath: Bivalirudin vs. Heparin the saga continues....
    Catheter Cardiovasc Interv. 2016;88:182-3.
    PubMed     Text format     Abstract available


    July 2016
  124. ROSSINI R, Angiolillo DJ, Musumeci G, Capodanno D, et al
    Antiplatelet therapy and outcome in patients undergoing surgery following coronary stenting: Results of the surgery after stenting registry.
    Catheter Cardiovasc Interv. 2016 Jul 12. doi: 10.1002/ccd.26629.
    PubMed     Text format     Abstract available


  125. COLLERAN R, Kufner S, Harada Y, Giacoppo D, et al
    Five-year follow-up of polymer-free sirolimus- and probucol-eluting stents versus new generation zotarolimus-eluting stents in patients presenting with st-elevation myocardial infarction.
    Catheter Cardiovasc Interv. 2016 Jul 5. doi: 10.1002/ccd.26597.
    PubMed     Text format     Abstract available


  126. MASHAYEKHI K, Behnes M, Valuckiene Z, Bryniarski L, et al
    Comparison of the ipsi-lateral versus contra-lateral retrograde approach of percutaneous coronary interventions in chronic total occlusions.
    Catheter Cardiovasc Interv. 2016 Jul 5. doi: 10.1002/ccd.26611.
    PubMed     Text format     Abstract available


  127. SAFIAN RD
    Saphenous vein bypass graft intervention and embolic protection devices: Time for reassessment (and revision of percutaneous coronary intervention guidelines).
    Catheter Cardiovasc Interv. 2016;88:84-5.
    PubMed     Text format     Abstract available


  128. COLLET C, Serruys PW
    Coronary bifurcations in clinical practice: Tell me what we can do better.
    Catheter Cardiovasc Interv. 2016;88:71-2.
    PubMed     Text format     Abstract available


  129. BUTMAN SM
    In early returns scoring scores big.
    Catheter Cardiovasc Interv. 2016;88:60-1.
    PubMed     Text format     Abstract available


  130. DANEK BA, Brilakis ES
    How to prevent and treat complications of the retrograde approach to chronic total occlusion percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2016;88:15-7.
    PubMed     Text format     Abstract available


    June 2016
  131. CHATTERJEE S, Yeh RW, Sardar P, Ul Hassan Virk H, et al
    Is multivessel intervention in ST-elevation myocardial infarction associated with early harm? Insights from observational data.
    Catheter Cardiovasc Interv. 2016 Jun 24. doi: 10.1002/ccd.26643.
    PubMed     Text format     Abstract available


  132. ARMSTRONG EJ, Graham L, Waldo SW, Valle JA, et al
    Patient and lesion-specific characteristics predict risk of major adverse cardiovascular events among patients with previous percutaneous coronary intervention undergoing noncardiac surgery.
    Catheter Cardiovasc Interv. 2016 Jun 17. doi: 10.1002/ccd.26624.
    PubMed     Text format     Abstract available


  133. ELLWEIN L, Marks DS, Migrino RQ, Foley WD, et al
    Image-based quantification of 3D morphology for bifurcations in the left coronary artery: Application to stent design.
    Catheter Cardiovasc Interv. 2016;87:1244-55.
    PubMed     Text format     Abstract available


  134. SHISHEHBOR MH, Aronow HD, Bartholomew JR, Beckman JA, et al
    Vascular specialist response to medicare evidence development coverage advisory committee (MEDCAC) panel on peripheral artery disease of the lower extremities.
    Catheter Cardiovasc Interv. 2016;87:1181-6.
    PubMed     Text format    


  135. SETO AH, Jordan Safirstein, Anwaruddin S, Dehghani P, et al
    Late breaking trials of 2015 in coronary artery disease: Commentary covering ACC, EuroPCR, SCAI, TCT, ESC, and AHA.
    Catheter Cardiovasc Interv. 2016;87:1224-30.
    PubMed     Text format     Abstract available


  136. QURESHI AM, Petit CJ, Crystal MA, Liou A, et al
    Efficacy and safety of catheter-based rheolytic and aspiration thrombectomy in children.
    Catheter Cardiovasc Interv. 2016;87:1273-80.
    PubMed     Text format     Abstract available


  137. HIRA RS, Dean LS
    Fork in the road: Are all bifurcations created equal?
    Catheter Cardiovasc Interv. 2016;87:1242-3.
    PubMed     Text format     Abstract available


  138. TOMMASO CL
    To aspirate or not!: The question may be not if, but when.
    Catheter Cardiovasc Interv. 2016;87:1211-2.
    PubMed     Text format     Abstract available


  139. SARDAR MR, Dawn Abbott J
    Myocardial salvage and mortality in STEMI: A race against ischemic time.
    Catheter Cardiovasc Interv. 2016;87:1201-2.
    PubMed     Text format     Abstract available


    May 2016
  140. FAZA NN, Mentias A, Parashar A, Chaudhury P, et al
    Bleeding Complications of Triple Antithrombotic Therapy after Percutaneous Coronary Interventions.
    Catheter Cardiovasc Interv. 2016 May 24. doi: 10.1002/ccd.26574.
    PubMed     Text format     Abstract available


  141. JOSHI FR, Biasco L, Pedersen F, Holmvang L, et al
    Invasive angiography and revascularization in patients with stable angina following prior coronary artery bypass grafting: Results from the East Denmark heart registry.
    Catheter Cardiovasc Interv. 2016 May 24. doi: 10.1002/ccd.26598.
    PubMed     Text format     Abstract available


  142. MURAI T, Kanaji Y, Yonetsu T, Lee T, et al
    Preprocedural fractional flow reserve and microvascular resistance predict increased hyperaemic coronary flow after elective percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2016 May 24. doi: 10.1002/ccd.26596.
    PubMed     Text format     Abstract available


  143. MAHMUD E, Dominguez A, Bahadorani J
    First-in-human robotic percutaneous coronary intervention for unprotected left main stenosis.
    Catheter Cardiovasc Interv. 2016 May 18. doi: 10.1002/ccd.26550.
    PubMed     Text format     Abstract available


  144. BOCKSCH W, Grossmann B, Geisler T, Steeg M, et al
    Clinical outcome and paravalvular leakage of the new balloon-expandable Edwards Sapien 3 valve in comparison to its predecessor model (Edwards Sapien XT) in patients undergoing transfemoral aortic valve replacement.
    Catheter Cardiovasc Interv. 2016 May 17. doi: 10.1002/ccd.26562.
    PubMed     Text format     Abstract available


  145. KARATASAKIS A, Tarar MN, Karmpaliotis D, Alaswad K, et al
    Guidewire and microcatheter utilization patterns during antegrade wire escalation in chronic total occlusion percutaneous coronary intervention: Insights from a contemporary multicenter registry.
    Catheter Cardiovasc Interv. 2016 May 17. doi: 10.1002/ccd.26568.
    PubMed     Text format     Abstract available


  146. CHANDRASEKHAR J, Baber U, Sartori S, Faggioni M, et al
    Sex-related differences in outcomes among men and women under 55 years of age with acute coronary syndrome undergoing percutaneous coronary intervention: Results from the PROMETHEUS Study.
    Catheter Cardiovasc Interv. 2016 May 6. doi: 10.1002/ccd.26606.
    PubMed     Text format     Abstract available


  147. GONSKA B, Seeger J, Rodewald C, Scharnbeck D, et al
    Transfemoral valve-in-valve implantation for degenerated bioprosthetic aortic valves using the new balloon-expandable Edwards Sapien 3 valve.
    Catheter Cardiovasc Interv. 2016 May 3. doi: 10.1002/ccd.26565.
    PubMed     Text format     Abstract available


  148. IPEK G, Gungor B, Karatas MB, Onuk T, et al
    Risk factors and outcomes in patients with ectatic infarct-related artery who underwent primary percutaneous coronary intervention after ST elevated myocardial infarction.
    Catheter Cardiovasc Interv. 2016 May 3. doi: 10.1002/ccd.26553.
    PubMed     Text format     Abstract available


  149. KAHLON TS, Barn K, Akram MM, Blankenship JC, et al
    Impact of pre-hospital electrocardiograms on time to treatment and one year outcome in a rural regional ST-segment elevation myocardial infarction network.
    Catheter Cardiovasc Interv. 2016 May 3. doi: 10.1002/ccd.26567.
    PubMed     Text format     Abstract available


  150. HARI P, Kirtane AJ, Bangalore S
    Retrograde approach to an ostial left anterior descending chronic total occlusion through a left internal mammary artery graft.
    Catheter Cardiovasc Interv. 2016;87:E224-8.
    PubMed     Text format     Abstract available


  151. BUNTE MC, House JA, Spertus JA, Cohen DJ, et al
    Association between health status and long-term mortality after percutaneous revascularization of peripheral artery disease.
    Catheter Cardiovasc Interv. 2016;87:1149-55.
    PubMed     Text format     Abstract available


  152. LADWINIEC A, Cunnington MS, Rossington J, Thackray S, et al
    Microvascular dysfunction in the immediate aftermath of chronic total coronary occlusion recanalization.
    Catheter Cardiovasc Interv. 2016;87:1071-9.
    PubMed     Text format     Abstract available


  153. MATSUMI J, Tobita K, Shishido K, Mizuno S, et al
    Comparison of long-term patency after endovascular therapy for superficial femoral artery occlusive disease between patients with and without hemodialysis.
    Catheter Cardiovasc Interv. 2016;87:1142-8.
    PubMed     Text format     Abstract available


  154. WOLFF R, Fefer P, Knudtson ML, Cheema AN, et al
    Gender differences in the prevalence and treatment of coronary chronic total occlusions.
    Catheter Cardiovasc Interv. 2016;87:1063-70.
    PubMed     Text format     Abstract available


  155. DE WOLF D, Dessy H, Haas N
    Use of a new low profile Occlutech PLD device for closure of Fontan fenestrations.
    Catheter Cardiovasc Interv. 2016;87:E243-7.
    PubMed     Text format     Abstract available


  156. PIHKALA JI, Jarvela M, Boldt T, Jokinen E, et al
    Fate of fenestration in children treated with fontan operation.
    Catheter Cardiovasc Interv. 2016;87:E233-9.
    PubMed     Text format     Abstract available


  157. LEVINE GN, Bates ER, Blankenship JC, Bailey SR, et al
    2015 ACC/AHA/SCAI focused update on primary percutaneous coronary intervention for patients with ST-elevation myocardial Infarction: An update of the 2011 ACCF/AHA/SCAI guideline for percutaneous coronary intervention and the 2013 ACCF/AHA guideline f
    Catheter Cardiovasc Interv. 2016;87:1001-19.
    PubMed     Text format    


  158. CARLINO M, Ruparelia N, Thomas G, Brooks M, et al
    Modified contrast microinjection technique to facilitate chronic total occlusion recanalization.
    Catheter Cardiovasc Interv. 2016;87:1036-41.
    PubMed     Text format     Abstract available


  159. MIYASAKA M, Tada N, Kato S, Kami M, et al
    Sheathless guide catheter in transradial percutaneous coronary intervention for ST-segment elevation myocardial infarction.
    Catheter Cardiovasc Interv. 2016;87:1111-7.
    PubMed     Text format     Abstract available


  160. LEE MH, Park JJ, Yoon CH, Cha MJ, et al
    Impact of smoking status on clinical outcomes after successful chronic total occlusion intervention: Korean national registry of CTO intervention.
    Catheter Cardiovasc Interv. 2016;87:1050-62.
    PubMed     Text format     Abstract available


  161. BUTERA G, Taha F
    Two problems and a single solution: Covered stent implantation to close an anterograde pulmonary flow and treat hypoplastic left pulmonary artery after Fontan operation.
    Catheter Cardiovasc Interv. 2016;87:E240-2.
    PubMed     Text format     Abstract available


  162. ORVIN K, Carrie D, Richardt G, Desmet W, et al
    Comparison of sirolimus eluting stent with bioresorbable polymer to everolimus eluting stent with permanent polymer in bifurcation lesions: Results from CENTURY II trial.
    Catheter Cardiovasc Interv. 2016;87:1092-100.
    PubMed     Text format     Abstract available


    April 2016
  163. O'NEILL BP, Wheatley G, Bashir R, Edmundowicz D, et al
    Study design and rationale of the heterotopic implantation of the Edwards-Sapien XT transcatheter valve in the inferior VEna cava for the treatment of severe tricuspid regurgitation (HOVER) trial.
    Catheter Cardiovasc Interv. 2016 Apr 28. doi: 10.1002/ccd.26530.
    PubMed     Text format     Abstract available


  164. CARLINO M, Azzalini L, Colombo A
    A novel maneuver to facilitate retrograde wire externalization during retrograde chronic total occlusion percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2016 Apr 28. doi: 10.1002/ccd.26556.
    PubMed     Text format     Abstract available


  165. ZAMAN S, Gooley R, Cheng V, McCormick L, et al
    Impact of routine crossover balloon occlusion technique on access-related vascular complications following transfemoral transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2016 Apr 23. doi: 10.1002/ccd.26371.
    PubMed     Text format     Abstract available


  166. TURNER ME, Addonizio LJ, Richmond ME, Zuckerman WA, et al
    Percutaneous coronary artery revascularization procedures in pediatric heart transplant recipients: A large single center experience.
    Catheter Cardiovasc Interv. 2016 Apr 16. doi: 10.1002/ccd.26544.
    PubMed     Text format     Abstract available


  167. HIRA RS, Dean LS
    STAR in CTO PCI: When is STAR not a star?
    Catheter Cardiovasc Interv. 2016;87:893-4.
    PubMed     Text format     Abstract available


  168. TURI ZG
    Does a vascular closure device affect the imbalance in complications between radial and femoral access?
    Catheter Cardiovasc Interv. 2016;87:855-6.
    PubMed     Text format     Abstract available


  169. VALLURUPALLI S, Uretsky BF
    Deploying bioresorbable vascular scaffolds--tardus, altius, amplius!!
    Catheter Cardiovasc Interv. 2016;87:847-8.
    PubMed     Text format     Abstract available


  170. OESTREICH BA, Sommer P, Armstrong EJ
    Coronary artery embolism from infectious endocarditis treated with catheter thrombectomy using a GuideLiner catheter.
    Catheter Cardiovasc Interv. 2016;87:E197-201.
    PubMed     Text format     Abstract available


  171. MAHMUD E, Blankenship JC
    SCAI: The educational home for interventional cardiovascular medicine professionals.
    Catheter Cardiovasc Interv. 2016;87:819-21.
    PubMed     Text format    


  172. BUTERA G, Lovin N, Basile DP, Carminati M, et al
    Goose-neck snare-assisted transcatheter ASD closure: A safety procedure for large and complex ASDs.
    Catheter Cardiovasc Interv. 2016;87:926-30.
    PubMed     Text format     Abstract available


  173. ILIESCU CA, Grines CL, Herrmann J, Yang EH, et al
    SCAI Expert consensus statement: Evaluation, management, and special considerations of cardio-oncology patients in the cardiac catheterization laboratory (endorsed by the cardiological society of india, and sociedad Latino Americana de Cardiologia int
    Catheter Cardiovasc Interv. 2016;87:E202-23.
    PubMed     Text format     Abstract available


  174. ILIESCU C, Grines CL, Herrmann J, Yang EH, et al
    SCAI expert consensus statement: Evaluation, management, and special considerations of cardio-oncology patients in the cardiac catheterization laboratory (Endorsed by the Cardiological Society of India, and Sociedad Latino Americana de Cardiologia Int
    Catheter Cardiovasc Interv. 2016;87:895-9.
    PubMed     Text format     Abstract available


  175. KERN MJ
    Conversations in cardiology--Is BVS ready for prime time? More about the absorb study.
    Catheter Cardiovasc Interv. 2016;87:902-8.
    PubMed     Text format    


  176. NOMURA T, Higuchi Y, Kato T
    Successful percutaneous coronary intervention for complex bifurcated lesions with combination of "Reverse wire technique" and "Reverse bent wiring with the crusade catheter" novel wire manipulation technique.
    Catheter Cardiovasc Interv. 2016;87:920-5.
    PubMed     Text format     Abstract available


  177. BIJUKLIC K, Schwencke C, Schofer J
    Recanalization of chronic total coronary occlusions--high success rate despite a restrictive use of the retrograde approach.
    Catheter Cardiovasc Interv. 2016;87:E183-91.
    PubMed     Text format     Abstract available


  178. FABRIS E, Caiazzo G, Kilic ID, Serdoz R, et al
    Is high pressure postdilation safe in bioresorbable vascular scaffolds? Optical coherence tomography observations after noncompliant balloons inflated at more than 24 atmospheres.
    Catheter Cardiovasc Interv. 2016;87:839-46.
    PubMed     Text format     Abstract available


  179. DAHAL K, Rijal J, Lee J, Korr KS, et al
    Transulnar versus transradial access for coronary angiography or percutaneous coronary intervention: A meta-analysis of randomized controlled trials.
    Catheter Cardiovasc Interv. 2016;87:857-65.
    PubMed     Text format     Abstract available


  180. TANAKA A, Ruparelia N, Kawamoto H, Sticchi A, et al
    Clinical outcomes following target lesion revascularization for bioresorbable scaffold failure.
    Catheter Cardiovasc Interv. 2016;87:832-6.
    PubMed     Text format     Abstract available


  181. CARLINO M, Figini F, Ruparelia N, Uretsky BF, et al
    Predictors of restenosis following contemporary subintimal tracking and reentry technique: The importance of final TIMI flow grade.
    Catheter Cardiovasc Interv. 2016;87:884-92.
    PubMed     Text format     Abstract available


  182. SCIAHBASI A, Rigattieri S, Sarandrea A, Cera M, et al
    Radial artery occlusion and hand strength after percutaneous coronary procedures: Results of the HANGAR study.
    Catheter Cardiovasc Interv. 2016;87:868-74.
    PubMed     Text format     Abstract available


  183. OTTERSPOOR LC, Van't Veer M, van Nunen LX, Wijnbergen I, et al
    Safety and feasibility of local myocardial hypothermia.
    Catheter Cardiovasc Interv. 2016;87:877-83.
    PubMed     Text format     Abstract available


  184. SUAREZ DE LEZO J, Martin P, Mazuelos F, Novoa J, et al
    Direct bioresorbable vascular scaffold implantation: Feasibility and midterm results.
    Catheter Cardiovasc Interv. 2016;87:E173-82.
    PubMed     Text format     Abstract available


  185. ALBUQUERQUE FN, Bortnick A, Iqbal J, Ishibashi Y, et al
    Dual antiplatelet therapy, drug-eluting stents and bioresorbable vascular scaffolds: Evolutionary perspectives.
    Catheter Cardiovasc Interv. 2016;87:909-19.
    PubMed     Text format     Abstract available


  186. PAPIREDDY MR, Nandish S, Mishkel GJ
    Recurrent spontaneous coronary artery dissection: First case report in men with three episodes of spontaneous coronary dissection in separate vascular territories.
    Catheter Cardiovasc Interv. 2016;87:E192-6.
    PubMed     Text format     Abstract available


  187. TOROK RD, Fleming GA, Hill KD
    Transcatheter pulmonary embolectomy after fontan.
    Catheter Cardiovasc Interv. 2016;87:939-44.
    PubMed     Text format     Abstract available


  188. LATINI RA, Granata F, Ielasi A, Varricchio A, et al
    Bioresorbable vascular scaffolds for small vessels coronary disease: The BVS-save registry.
    Catheter Cardiovasc Interv. 2016 Apr 1. doi: 10.1002/ccd.26516.
    PubMed     Text format     Abstract available


    March 2016
  189. SOLHPOUR A, Chang KW, Arain SA, Balan P, et al
    Comparison of 30-day mortality and myocardial scar indices for patients treated with prehospital reduced dose fibrinolytic followed by percutaneous coronary intervention versus percutaneous coronary intervention alone for treatment of ST-elevation myo
    Catheter Cardiovasc Interv. 2016 Mar 29. doi: 10.1002/ccd.26523.
    PubMed     Text format     Abstract available


  190. ADUSUMALLI S, Morris M, Pershad A
    Pseudo-Pericardial Tamponade From Right Ventricular Hematoma After Chronic Total Occlusion Percutaneous Coronary Intervention of the Right Coronary Artery: Successfully Managed Percutaneously With Computerized Tomographic Guided Drainage.
    Catheter Cardiovasc Interv. 2016 Mar 29. doi: 10.1002/ccd.26510.
    PubMed     Text format     Abstract available


  191. STETLER J, Karatasakis A, Christakopoulos GE, Tarar MN, et al
    Impact of crossing technique on the incidence of periprocedural myocardial infarction during chronic total occlusion percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2016 Mar 25. doi: 10.1002/ccd.26505.
    PubMed     Text format     Abstract available


  192. IKEDA N, Kubota S, Okazaki T, Hara H, et al
    Comparison of intravascular optical frequency domain imaging versus intravascular ultrasound during balloon pulmonary angioplasty in patients with chronic thromboembolic pulmonary hypertension.
    Catheter Cardiovasc Interv. 2016 Mar 18. doi: 10.1002/ccd.26437.
    PubMed     Text format     Abstract available


  193. KLEIN LW, Blankenship JC, Kolansky DM, Dean LS, et al
    SCAI position statement concerning coverage policies for percutaneous coronary interventions based on the appropriate use criteria.
    Catheter Cardiovasc Interv. 2016 Mar 10. doi: 10.1002/ccd.26499.
    PubMed     Text format    


  194. PRASAD A, Ortiz-Lopez C, Khan A, Levin D, et al
    Acute kidney injury following peripheral angiography and endovascular therapy: A systematic review of the literature.
    Catheter Cardiovasc Interv. 2016 Mar 4. doi: 10.1002/ccd.26466.
    PubMed     Text format     Abstract available


  195. MARKOVIC S, Lutzner M, Rottbauer W, Wohrle J, et al
    Zotarolimus compared with everolimus eluting stents-angiographic and clinical results after recanalization of true coronary chronic total occlusions.
    Catheter Cardiovasc Interv. 2016 Mar 4. doi: 10.1002/ccd.26482.
    PubMed     Text format     Abstract available


  196. IQBAL MB, Nadra IJ, Ding L, Fung A, et al
    Long-term outcomes following drug-eluting stents versus bare metal stents for primary percutaneous coronary intervention: A real-world analysis of 11,181 patients from the british columbia cardiac registry.
    Catheter Cardiovasc Interv. 2016 Mar 4. doi: 10.1002/ccd.26479.
    PubMed     Text format     Abstract available


  197. KRAJCER Z, Echeverria A
    The "open branch" technique: A new way to prevent paraplegia after total endovascular repair of thoracoabdominal aneurysm.
    Catheter Cardiovasc Interv. 2016;87:781-2.
    PubMed     Text format     Abstract available


  198. BANG VV, Levy MS
    Duration of dual anti-platelet therapy following drug eluting stents: Less Is More?
    Catheter Cardiovasc Interv. 2016;87:733-4.
    PubMed     Text format     Abstract available


  199. KARATASAKIS A, Brilakis ES
    Atherectomy for calcified coronary lesions: When and how?
    Catheter Cardiovasc Interv. 2016;87:701-2.
    PubMed     Text format     Abstract available


  200. CHANDRASEKHAR J, Mehran R
    Orbital atherectomy for severely calcified lesions: More dissections in women but similar 30-day outcomes to men.
    Catheter Cardiovasc Interv. 2016;87:678-9.
    PubMed     Text format     Abstract available


  201. BUTMAN SM
    Our aspirations still disappoint.
    Catheter Cardiovasc Interv. 2016;87:661-2.
    PubMed     Text format     Abstract available


  202. BLANKENSHIP JC
    When in doubt, aspirate.
    Catheter Cardiovasc Interv. 2016;87:648-9.
    PubMed     Text format     Abstract available


  203. BAILEY SR
    Catheterization and Cardiovascular Interventions CIT special issue: Editor in chief editorial.
    Catheter Cardiovasc Interv. 2016;87 Suppl 1:551.
    PubMed     Text format    


  204. MASTORIS I, Giustino G, Sartori S, Baber U, et al
    Efficacy and safety of routine thrombus aspiration in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: An updated systematic review and meta-analysis of randomized controlled trials.
    Catheter Cardiovasc Interv. 2016;87:650-60.
    PubMed     Text format     Abstract available


  205. DU ZK, Wang Y, Wang XZ, Jing QM, et al
    Influence of distal extension of false lumen on adverse aortic events after TEVAR in patients with acute type B aortic dissection.
    Catheter Cardiovasc Interv. 2016;87 Suppl 1:599-607.
    PubMed     Text format     Abstract available


  206. WU Y, Shen L, Ge L, Wang Q, et al
    Six-month outcomes of the XINSORB bioresorbable sirolimus-eluting scaffold in treating single de novo lesions in human coronary artery.
    Catheter Cardiovasc Interv. 2016;87 Suppl 1:630-7.
    PubMed     Text format     Abstract available


  207. CHEN X, Zhang D, Yin D, Li J, et al
    Can "true bifurcation lesion" actually be regarded as an independent risk factor of acute side branch occlusion after main vessel stenting?: A retrospective analysis of 1,200 consecutive bifurcation lesions in a single center.
    Catheter Cardiovasc Interv. 2016;87 Suppl 1:554-63.
    PubMed     Text format     Abstract available


  208. XU B, Qian J, Ge J, Wang J, et al
    Two-year results and subgroup analyses of the PEPCAD China in-stent restenosis trial: A prospective, multicenter, randomized trial for the treatment of drug-eluting stent in-stent restenosis.
    Catheter Cardiovasc Interv. 2016;87 Suppl 1:624-9.
    PubMed     Text format     Abstract available


  209. GROHMANN J, Sigler M, Siepe M, Stiller B, et al
    A new breakable stent for recoarctation in early infancy: Preliminary Clinical Experience.
    Catheter Cardiovasc Interv. 2016;87:E143-50.
    PubMed     Text format     Abstract available


  210. MANGIALARDI N, Lachat M, Esposito A, Puippe G, et al
    The "Open Branch" Technique: A New Way to Prevent Paraplegia After Total Endovascular Repair of Thoracoabdominal Aneurysm.
    Catheter Cardiovasc Interv. 2016;87:773-80.
    PubMed     Text format     Abstract available


  211. GALINANES EL, Hernandez E, Krajcer Z
    Preliminary results of adjunctive use of endoanchors in the treatment of short neck and pararenal abdominal aortic aneurysms.
    Catheter Cardiovasc Interv. 2016;87:E154-9.
    PubMed     Text format     Abstract available


  212. CHOUDHRY S, Balzer D, Murphy J, Nicolas R, et al
    Percutaneous carotid artery access in infants < 3 months of age.
    Catheter Cardiovasc Interv. 2016;87:757-61.
    PubMed     Text format     Abstract available


  213. TANAKA Y, Saito S
    Successful retrieval of a firmly stuck rotablator burr by using a modified STAR technique.
    Catheter Cardiovasc Interv. 2016;87:749-56.
    PubMed     Text format     Abstract available


  214. HELMY TA, Sanchez CE, Bailey SR
    Coronary and peripheral stenting in aorto-ostial protruding stents: The balloon assisted access to protruding stent technique.
    Catheter Cardiovasc Interv. 2016;87:735-41.
    PubMed     Text format     Abstract available


  215. SECCO GG, Serdoz R, Kilic ID, Caiazzo G, et al
    Indications and immediate and long-term results of a novel pericardium covered stent graft: Consecutive 5 year single center experience.
    Catheter Cardiovasc Interv. 2016;87:712-9.
    PubMed     Text format     Abstract available


  216. DE WAHA S, Allali A, Buttner HJ, Toelg R, et al
    Rotational atherectomy before paclitaxel-eluting stent implantation in complex calcified coronary lesions: Two-year clinical outcome of the randomized ROTAXUS trial.
    Catheter Cardiovasc Interv. 2016;87:691-700.
    PubMed     Text format     Abstract available


  217. BANZIC I, Lachat M, Rancic Z
    Aortic rupture following an EVAR secondary to graft erosion.
    Catheter Cardiovasc Interv. 2016;87:783-6.
    PubMed     Text format     Abstract available


  218. GIUSTINO G, Baber U, Mastoris I, Vlachojannis GJ, et al
    One-year results of the ICON (Ionic versus non-ionic Contrast to Obviate worsening Nephropathy after angioplasty in chronic renal failure patients) Study.
    Catheter Cardiovasc Interv. 2016;87:703-9.
    PubMed     Text format     Abstract available


  219. AMANN U, Kirchberger I, Heier M, von Scheidt W, et al
    Acute myocardial infarction in the elderly: Treatment strategies and 28-day-case fatality from the MONICA/KORA myocardial infarction registry.
    Catheter Cardiovasc Interv. 2016;87:680-8.
    PubMed     Text format     Abstract available


  220. VO MN, Karmpaliotis D, Brilakis ES
    "Move the cap" technique for ambiguous or impenetrable proximal cap of coronary total occlusion.
    Catheter Cardiovasc Interv. 2016;87:742-8.
    PubMed     Text format     Abstract available


  221. KIM CY, Lee AC, Wiedenbeck TL, Lee MS, et al
    Gender differences in acute and 30-day outcomes after orbital atherectomy treatment of de novo, severely calcified coronary lesions.
    Catheter Cardiovasc Interv. 2016;87:671-7.
    PubMed     Text format     Abstract available


  222. ZIADA KM, Abdel-Latif A, Charnigo R, Moliterno DJ, et al
    Safety of an abbreviated duration of dual antiplatelet therapy (</=6 months) following second-generation drug-eluting stents for coronary artery disease: A systematic review and meta-analysis of randomized trials.
    Catheter Cardiovasc Interv. 2016;87:722-32.
    PubMed     Text format     Abstract available


  223. KARJALAINEN PP, Mikkelsson J, Paana T, Nammas W, et al
    Clinical outcome of titanium-nitride-oxide-coated cobalt-chromium stents in patients with de novo coronary lesions: 12-month results of the OPTIMAX first-in-man study.
    Catheter Cardiovasc Interv. 2016;87:E122-7.
    PubMed     Text format     Abstract available


  224. WORRALL-CARTER L, McEvedy S, Wilson A, Rahman MA, et al
    Impact of comorbidities and gender on the use of coronary interventions in patients with high-risk non-ST-segment elevation acute coronary syndrome.
    Catheter Cardiovasc Interv. 2016;87:E128-36.
    PubMed     Text format     Abstract available


  225. WANG TY, Grines C, Ortega R, Dai D, et al
    Women in interventional cardiology: Update in percutaneous coronary intervention practice patterns and outcomes of female operators from the National Cardiovascular Data Registry(R).
    Catheter Cardiovasc Interv. 2016;87:663-8.
    PubMed     Text format     Abstract available


  226. HISHIKARI K, Kakuta T, Lee T, Murai T, et al
    ST-segment elevation on intracoronary electrocardiogram after percutaneous coronary intervention is associated with worse outcome in patients with non-ST-segment elevation myocardial infarction.
    Catheter Cardiovasc Interv. 2016;87:E113-21.
    PubMed     Text format     Abstract available


  227. HUANG AL, Murphy JC, Shaw E, Kozor R, et al
    Routine aspiration thrombectomy improves the diagnosis and management of embolic myocardial infarction.
    Catheter Cardiovasc Interv. 2016;87:642-7.
    PubMed     Text format     Abstract available


  228. MORRIS PD, Taylor J, Boutong S, Brett S, et al
    When is rotational angiography superior to conventional single-plane angiography for planning coronary angioplasty?
    Catheter Cardiovasc Interv. 2016;87:E104-12.
    PubMed     Text format     Abstract available


  229. NAKAJIMA Y, Itoh T, Morino Y
    Metal allergy to everolimus-eluting cobalt chromium stents confirmed by positive skin testing as a cause of recurrent multivessel in-stent restenosis.
    Catheter Cardiovasc Interv. 2016;87:E137-42.
    PubMed     Text format     Abstract available


    February 2016
  230. PHILIP F, Stewart S, Southard JA
    Very late stent thrombosis with second generation drug eluting stents compared to bare metal stents: Network meta-analysis of randomized primary percutaneous coronary intervention trials.
    Catheter Cardiovasc Interv. 2016 Feb 24. doi: 10.1002/ccd.26458.
    PubMed     Text format     Abstract available


  231. CHE WQ, Dong H, Jiang XJ, Peng M, et al
    Stenting for left subclavian artery stenosis in patients scheduled for left internal mammary artery-coronary artery bypass grafting.
    Catheter Cardiovasc Interv. 2016 Feb 23. doi: 10.1002/ccd.26477.
    PubMed     Text format     Abstract available


  232. RITTGER H, Wohrle J, Brachmann J, Hohenforst-Schmidt W, et al
    Angiographic patterns of drug-eluting stent restenosis after treatment with drug-coated balloon versus balloon angioplasty: Late lumen loss subgroup analyses of the PEPCAD-DES study.
    Catheter Cardiovasc Interv. 2016 Feb 19. doi: 10.1002/ccd.26451.
    PubMed     Text format     Abstract available


  233. HEUSER R
    Stroke care: Room for improvement.
    Catheter Cardiovasc Interv. 2016;87:465-6.
    PubMed     Text format     Abstract available


  234. SAFIAN RD
    Double cerebral embolic protection: Is more less?
    Catheter Cardiovasc Interv. 2016;87:438-9.
    PubMed     Text format     Abstract available


  235. HILLEGASS WB
    Risk-guided use of the direct thrombin inhibitor bivalirudin.
    Catheter Cardiovasc Interv. 2016;87:401-2.
    PubMed     Text format     Abstract available


  236. BADER Y, Kimmelstiel C
    Thrombin inhibition during PCI in heart failure patients.
    Catheter Cardiovasc Interv. 2016;87:374-5.
    PubMed     Text format     Abstract available


  237. LU W, Fu W, Si Y, Chen X, et al
    A novel endovascular occlusion device with a steerable introducer for embolization in a porcine model.
    Catheter Cardiovasc Interv. 2016;87:E86-96.
    PubMed     Text format     Abstract available


  238. YU J, Mehran R, Clayton T, Gibson CM, et al
    Prediction of 1-year mortality and impact of bivalirudin therapy according to level of baseline risk: A patient-level pooled analysis from three randomized trials.
    Catheter Cardiovasc Interv. 2016;87:391-400.
    PubMed     Text format     Abstract available


  239. JIANG Y, Li Y, Xu X, Yu Y, et al
    An in vitro porcine model evaluating a novel stent retriever for thrombectomy of the common carotid artery.
    Catheter Cardiovasc Interv. 2016;87:457-64.
    PubMed     Text format     Abstract available


  240. MISENHEIMER JA, Poommipanit P, Amin Z
    Retrograde percutaneous repair of aortic coarctation utilizing trans-septal puncture in patients with complex anatomy.
    Catheter Cardiovasc Interv. 2016;87:446-50.
    PubMed     Text format     Abstract available


  241. GURM HS, Sanz-Guerrero J, Johnson DD, Jensen A, et al
    Using simulation for teaching femoral arterial access: A multicentric collaboration.
    Catheter Cardiovasc Interv. 2016;87:376-80.
    PubMed     Text format     Abstract available


  242. CARDOSO R, Ansari M, Garcia D, Sandhu S, et al
    Prestenting for prevention of melody valve stent fractures: A systematic review and meta-analysis.
    Catheter Cardiovasc Interv. 2016;87:534-9.
    PubMed     Text format     Abstract available


  243. VARBELLA F, Gagnor A, Rolfo C, Cerrato E, et al
    Feasibility of carotid artery stenting with double cerebral embolic protection in high-risk patients.
    Catheter Cardiovasc Interv. 2016;87:432-7.
    PubMed     Text format     Abstract available


  244. YAMAGUCHI S, Zen K, Kambayashi D
    A side-grooved guiding sheath as an effective treatment strategy for femoro-popliteal artery lesions.
    Catheter Cardiovasc Interv. 2016;87:451-6.
    PubMed     Text format     Abstract available


  245. ABU HAZEEM A, Aldoss O, Fagan T
    A novel method to prevent recurrent balloon rupture during dilation of heavily calcified conduits in preparation for transcatheter pulmonary valve placement.
    Catheter Cardiovasc Interv. 2016;87:421-5.
    PubMed     Text format     Abstract available


  246. ZHANG Q, Hu J, Yang ZK, Ding FH, et al
    Correlates and outcomes related to periprocedural myocardial injury during percutaneous coronary intervention for chronic total occlusion: Results from a prospective, single center PCI registry.
    Catheter Cardiovasc Interv. 2016 Feb 10. doi: 10.1002/ccd.26406.
    PubMed     Text format     Abstract available


  247. GILCHRIST IC, Schmidt TR
    It is not paradoxical: Risk reduction from transradial occurs across all weight classes proportional to baseline risk.
    Catheter Cardiovasc Interv. 2016;87:220-1.
    PubMed     Text format    


  248. SAFIAN RD
    Restenosis after PCI: Battered but not beaten.
    Catheter Cardiovasc Interv. 2016;87:209-10.
    PubMed     Text format    


  249. BLANKENSHIP JC
    SCAI's future: The 2016 Strategic Plan.
    Catheter Cardiovasc Interv. 2016;87:183-7.
    PubMed     Text format    


  250. ARONOW HD, Collins TJ, Gray WA, Jaff MR, et al
    SCAI/SVM expert consensus statement on carotid stenting: Training and credentialing for carotid stenting.
    Catheter Cardiovasc Interv. 2016;87:188-99.
    PubMed     Text format     Abstract available


  251. PEREIRA-DA-SILVA T, Martins JD, de Sousa L, Fiarresga A, et al
    Percutaneous occlusion of vascular malformations in pediatric and adult patients: 20-year experience of a single center.
    Catheter Cardiovasc Interv. 2016;87:E62-8.
    PubMed     Text format     Abstract available


  252. SAKAMOTO N, Hoshino Y, Mizukami H, Sugimoto K, et al
    Intravascular ultrasound predictors of acute side branch occlusion in coronary artery bifurcation lesions just after single stent crossover.
    Catheter Cardiovasc Interv. 2016;87:243-50.
    PubMed     Text format     Abstract available


  253. MCDONAGH JR, Seth M, LaLonde TA, Khandewal AK, et al
    Radial PCI and the obesity paradox: Insights from Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2).
    Catheter Cardiovasc Interv. 2016;87:211-9.
    PubMed     Text format     Abstract available


  254. HONDA Y, Muramatsu T, Ito Y, Sakai T, et al
    Impact of ultra-long second-generation drug-eluting stent implantation.
    Catheter Cardiovasc Interv. 2016;87:E44-53.
    PubMed     Text format     Abstract available


  255. BENJO A, Cardoso RN, Collins T, Garcia D, et al
    Vascular brachytherapy versus drug-eluting stents in the treatment of in-stent restenosis: A meta-analysis of long-term outcomes.
    Catheter Cardiovasc Interv. 2016;87:200-8.
    PubMed     Text format     Abstract available


  256. MCCROSSAN BA, McMahon CJ, Walsh KP
    First reported use of drug-eluting bioabsorbable vascular scaffold in congenital heart disease.
    Catheter Cardiovasc Interv. 2016;87:324-8.
    PubMed     Text format     Abstract available


  257. BELARDI J, Manoharan G, Albertal M, Widimsky P, et al
    The influence of age on clinical outcomes in patients treated with the resolute zotarolimus-eluting stent.
    Catheter Cardiovasc Interv. 2016;87:253-61.
    PubMed     Text format     Abstract available


  258. PATEL Y, Depta JP, Patel JS, Masrani SK, et al
    Impact of intravascular ultrasound on the long-term clinical outcomes in the treatment of coronary ostial lesions.
    Catheter Cardiovasc Interv. 2016;87:232-40.
    PubMed     Text format     Abstract available


  259. GREQUE GV, Serrano CV Jr, Strunz CM, Soeiro A, et al
    Preprocedural statin therapy, inflammation, and myocardial injury in low-risk stable coronary artery disease patients submitted to coronary stent implantation.
    Catheter Cardiovasc Interv. 2016;87:222-9.
    PubMed     Text format     Abstract available


  260. KHAN R, Al-Hawwas M, Hatem R, Azzalini L, et al
    Prognostic impact of the residual SYNTAX score on in-hospital outcomes in patients undergoing primary percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2016 Feb 1. doi: 10.1002/ccd.26413.
    PubMed     Text format     Abstract available


    January 2016
  261. DONG H, Jiang X, Peng M, Zou Y, et al
    The interval between carotid artery stenting and open heart surgery is related to perioperative complications.
    Catheter Cardiovasc Interv. 2016 Jan 26. doi: 10.1002/ccd.26408.
    PubMed     Text format     Abstract available


  262. LIANG Z, Li Y, Wang J, Wang D, et al
    The safety and effectiveness of bivalirudin in female patients with acute myocardial infarction undergoing primary angioplasty: A subgroup analysis of the BRIGHT trial.
    Catheter Cardiovasc Interv. 2016 Jan 13. doi: 10.1002/ccd.26407.
    PubMed     Text format     Abstract available


  263. PINTON FA, Lemos PA
    Inflation time in stent deployment: How long is enough?
    Catheter Cardiovasc Interv. 2016;87:73-4.
    PubMed     Text format     Abstract available


  264. HILLEGASS WB
    Insulin-treated diabetes mellitus: An important, actionable risk marker after coronary stenting.
    Catheter Cardiovasc Interv. 2016;87:63-4.
    PubMed     Text format     Abstract available


  265. PATEL PM, Kern MJ
    PCI in failing saphenous vein grafts: DES trumps BMS for the older patient.
    Catheter Cardiovasc Interv. 2016;87:50-1.
    PubMed     Text format     Abstract available


  266. KOLTE D, Dawn Abbott J
    Saphenous vein graft lesions: Are second-generation drug-eluting stents better?
    Catheter Cardiovasc Interv. 2016;87:41-2.
    PubMed     Text format     Abstract available


  267. HIGASHIMORI A, Iida O, Yamauchi Y, Kawasaki D, et al
    Outcomes of One straight-line flow with and without pedal arch in patients with critical limb ischemia.
    Catheter Cardiovasc Interv. 2016;87:129-33.
    PubMed     Text format     Abstract available


  268. MATSUO Y, Kubo T, Aoki H, Satogami K, et al
    Optimal threshold of postintervention minimum stent area to predict in-stent restenosis in small coronary arteries: An optical coherence tomography analysis.
    Catheter Cardiovasc Interv. 2016;87:E9-E14.
    PubMed     Text format     Abstract available


  269. BRENNAN JM, Sketch MH Jr, Dai D, Trilesskaya M, et al
    Safety and clinical effectiveness of drug-eluting stents for saphenous vein graft intervention in older individuals: Results from the medicare-linked National Cardiovascular Data Registry((R)) CathPCI Registry((R)) (2005-2009).
    Catheter Cardiovasc Interv. 2016;87:43-9.
    PubMed     Text format     Abstract available


  270. VALLURUPALLI S, Bahia A, Ruiz-Rodriguez E, Ahmed Z, et al
    Optimization of stent implantation using a high pressure inflation protocol.
    Catheter Cardiovasc Interv. 2016;87:65-72.
    PubMed     Text format     Abstract available


  271. URETSKY BF, Mathew J, Ahmed Z, Hakeem A, et al
    Percutaneous management of patients with acute coronary syndromes from unprotected left main disease: A comprehensive review and presentation of a treatment algorithm.
    Catheter Cardiovasc Interv. 2016;87:90-100.
    PubMed     Text format     Abstract available


  272. CARRABBA N, Parodi G, Maehara A, Pradella S, et al
    Rheolityc thrombectomy in acute myocardial infarction: Effect on microvascular obstruction, infarct size, and left ventricular remodeling.
    Catheter Cardiovasc Interv. 2016;87:E1-8.
    PubMed     Text format     Abstract available


  273. POKALA NR, Menon RV, Patel SM, Christopoulos G, et al
    Long-term outcomes with first- vs. second-generation drug-eluting stents in saphenous vein graft lesions.
    Catheter Cardiovasc Interv. 2016;87:34-40.
    PubMed     Text format     Abstract available


  274. PANAICH SS, Badheka AO, Arora S, Patel NJ, et al
    Variability in utilization of drug eluting stents in United States: Insights from nationwide inpatient sample.
    Catheter Cardiovasc Interv. 2016;87:23-33.
    PubMed     Text format     Abstract available


  275. BARTORELLI AL, Egidy Assenza G, Abizaid A, Banning A, et al
    One-year clinical outcomes after sirolimus-eluting coronary stent implantation in diabetics enrolled in the worldwide e-SELECT registry.
    Catheter Cardiovasc Interv. 2016;87:52-62.
    PubMed     Text format     Abstract available


  276. KATOH H, Nozue T, Michishita I
    A case of giant saphenous vein graft aneurysm successfully treated with catheter intervention.
    Catheter Cardiovasc Interv. 2016;87:83-9.
    PubMed     Text format     Abstract available


  277. BURZOTTA F, Summaria F, Latib A, De Vita M, et al
    Prospective multicentre clinical performance evaluation of second and third generation zotarolimus-eluting stents to treat patients with bifurcated coronary lesions.
    Catheter Cardiovasc Interv. 2016;87:15-22.
    PubMed     Text format     Abstract available


  278. LU H, Ge L, Ge J
    Coronary aneurysm and stent fracture following stenting of a myocardial bridge.
    Catheter Cardiovasc Interv. 2016;87:E15-8.
    PubMed     Text format     Abstract available


    December 2015
  279. HABARA M, Tsuchikane E, Muramatsu T, Kashima Y, et al
    Comparison of percutaneous coronary intervention for chronic total occlusion outcome according to operator experience from the Japanese retrograde summit registry.
    Catheter Cardiovasc Interv. 2015 Dec 31. doi: 10.1002/ccd.26354.
    PubMed     Text format     Abstract available


  280. HOPPMANN P, Kufner S, Cassese S, Wiebe J, et al
    Angiographic and clinical outcomes of patients treated with everolimus-eluting bioresorbable stents in routine clinical practice: Results of the ISAR-ABSORB registry.
    Catheter Cardiovasc Interv. 2015 Dec 28. doi: 10.1002/ccd.26346.
    PubMed     Text format     Abstract available


  281. LEE MS, Mustapha J, Beasley R, Chopra P, et al
    Impact of lesion location on procedural and acute angiographic outcomes in patients with critical limb ischemia treated for peripheral artery disease with orbital atherectomy: A CONFIRM registries subanalysis.
    Catheter Cardiovasc Interv. 2015 Dec 9. doi: 10.1002/ccd.26349.
    PubMed     Text format     Abstract available


  282. PASS RH
    Letter regarding: Bronchoscopic guidance of endovascular stenting limits airway compression.
    Catheter Cardiovasc Interv. 2015;86:1299.
    PubMed     Text format    


  283. EL-SAID H
    Rebuttal.
    Catheter Cardiovasc Interv. 2015;86:1300-1.
    PubMed     Text format    


    November 2015
  284. MONT'ALVERNE-FILHO JR, Rodrigues-Sobrinho CR, Medeiros F, Falcao FC, et al
    Upstream clopidogrel, prasugrel, or ticagrelor for patients treated with primary angioplasty: Results of an angiographic randomized pilot study.
    Catheter Cardiovasc Interv. 2015 Nov 28. doi: 10.1002/ccd.26334.
    PubMed     Text format     Abstract available


  285. NASCIMBENE A, Loyalka P, Gregoric ID, Kar B, et al
    Percutaneous coronary intervention with the TandemHeart percutaneous left ventricular assist device support: Six years of experience and outcomes.
    Catheter Cardiovasc Interv. 2015 Nov 21. doi: 10.1002/ccd.26147.
    PubMed     Text format     Abstract available


  286. LARMORE C, Effron MB, Molife C, DeKoven M, et al
    "Real-World" comparison of prasugrel with ticagrelor in patients with acute coronary syndrome treated with percutaneous coronary intervention in the United States.
    Catheter Cardiovasc Interv. 2015 Nov 18. doi: 10.1002/ccd.26279.
    PubMed     Text format     Abstract available


  287. KIM SM, Moliterno DJ
    Ageless benefits of transradial access for percutaneous coronary revascularization.
    Catheter Cardiovasc Interv. 2015;86:973-4.
    PubMed     Text format     Abstract available


  288. YOSHIMACHI F, Torii S, Naito T
    A novel percutaneous coronary intervention technique for chronic total occlusion: Contralateral angiography with a single guiding catheter.
    Catheter Cardiovasc Interv. 2015 Nov 3. doi: 10.1002/ccd.26268.
    PubMed     Text format     Abstract available


  289. JANG WJ, Yang JH, Choi SH, Song YB, et al
    Association of periprocedural myocardial infarction with long-term survival in patients treated with coronary revascularization therapy of chronic total occlusion.
    Catheter Cardiovasc Interv. 2015 Nov 3. doi: 10.1002/ccd.26286.
    PubMed     Text format     Abstract available


  290. ELGENDY IY, Wen X, Mahmoud A, Bavry AA, et al
    Complete versus culprit-only revascularization for patients with multi-vessel disease undergoing primary percutaneous coronary intervention: An updated meta-analysis of randomized trials.
    Catheter Cardiovasc Interv. 2015 Nov 3. doi: 10.1002/ccd.26322.
    PubMed     Text format     Abstract available


    September 2015
  291. PRASAD A, Ortiz-Lopez C, Kaye DM, Byrne M, et al
    The use of the AVERT system to limit contrast volume administration during peripheral angiography and intervention.
    Catheter Cardiovasc Interv. 2015 Sep 21. doi: 10.1002/ccd.26155.
    PubMed     Text format     Abstract available


  292. LEDERMAN RJ, Babaliaros VC, Greenbaum AB
    How to perform transcaval access and closure for transcatheter aortic valve implantation.
    Catheter Cardiovasc Interv. 2015 Sep 10. doi: 10.1002/ccd.26141.
    PubMed     Text format     Abstract available


  293. SINGH RAO R, Shapiro RL, Lasala JM
    No reflow leading to catastrophic hemodynamic collapse in a patient with severe aortic stenosis and its management.
    Catheter Cardiovasc Interv. 2015 Sep 10. doi: 10.1002/ccd.26233.
    PubMed     Text format     Abstract available


  294. SALEH N, De Palma R, Settergren M, Ruck A, et al
    Femoral access-related complications during percutaneous transcatheter aortic valve implantation comparing single versus double Prostar XL device closure.
    Catheter Cardiovasc Interv. 2015 Sep 2. doi: 10.1002/ccd.25966.
    PubMed     Text format     Abstract available


  295. KHEIWA A, Turner D, Schreiber T
    Left main coronary artery embolization in an 11-year-old girl due to inflammatory myofibroblastic tumor of the mitral valve.
    Catheter Cardiovasc Interv. 2015 Sep 2. doi: 10.1002/ccd.26149.
    PubMed     Text format     Abstract available


  296. HILLEGASS WB
    Diabetes is not sufficient justification for IIb/IIIa use in percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2015;86:376-7.
    PubMed     Text format     Abstract available


    August 2015
  297. BASIR MB, Velez C, Fuller B, Wyman J, et al
    Rates of vascular access use in transcatheter aortic valve replacement: A look into the next generation.
    Catheter Cardiovasc Interv. 2015 Aug 10. doi: 10.1002/ccd.26116.
    PubMed     Text format     Abstract available


    July 2015
  298. ANGELINI P, Uribe C, Monge J, Tobis JM, et al
    Origin of the right coronary artery from the opposite sinus of Valsalva in adults: Characterization by intravascular ultrasonography at baseline and after stent angioplasty.
    Catheter Cardiovasc Interv. 2015 Jul 14. doi: 10.1002/ccd.26069.
    PubMed     Text format     Abstract available


  299. GUPTA K, Prasad A
    A call for long-term data in clinical studies of infrainguinal peripheral arterial revascularization: The DURABILITY II Study delivers.
    Catheter Cardiovasc Interv. 2015;86:171-2.
    PubMed     Text format     Abstract available


  300. LIPINSKI MJ, Satler LF
    Intraprocedural thrombotic events: What's the real cost?
    Catheter Cardiovasc Interv. 2015;86:40-1.
    PubMed     Text format     Abstract available


  301. GILCHRIST IC
    Eliminate the sheath and maximize the working space: Sheathless transradial guiding catheters.
    Catheter Cardiovasc Interv. 2015;86:59-60.
    PubMed     Text format     Abstract available


  302. BUTMAN S
    Cerebroradial issue: Not so much.
    Catheter Cardiovasc Interv. 2015;86:71-2.
    PubMed     Text format     Abstract available


  303. CILINGIROGLU M, Patel RA, Dean LS
    Late breaking trials of 2014 in structural heart disease and peripheral arterial disease: Commentary covering ACC, EuroPCR, SCAI, TCT, VIVA, ESC, and AHA.
    Catheter Cardiovasc Interv. 2015;86:80-4.
    PubMed     Text format     Abstract available


  304. PLENT S, Fan W, Kirtane A, Brener SJ, et al
    Cost implications of intraprocedural thrombotic events during PCI.
    Catheter Cardiovasc Interv. 2015;86:30-9.
    PubMed     Text format     Abstract available


  305. ROCHA-SINGH KJ, Bosiers M, Schultz G, Jaff MR, et al
    A single stent strategy in patients with lifestyle limiting claudication: 3-year results from the Durability II trial.
    Catheter Cardiovasc Interv. 2015;86:164-70.
    PubMed     Text format     Abstract available


  306. RAPOSO L, Madeira S, Teles RC, Santos M, et al
    Neurologic complications after transradial or transfemoral approach for diagnostic and interventional cardiac catheterization: A propensity score analysis of 16,710 cases from a single centre prospective registry.
    Catheter Cardiovasc Interv. 2015;86:61-70.
    PubMed     Text format     Abstract available


  307. MIYAZAKI T, Latib A, Panoulas VF, Miyazaki S, et al
    Comparison of 2-year outcomes between zotarolimus-eluting and everolimus-eluting new-generation cobalt-chromium alloy stents in real-world diabetic patients.
    Catheter Cardiovasc Interv. 2015;86:E11-8.
    PubMed     Text format     Abstract available


  308. WITBERG G, Lavi I, Assali A, Vaknin-Assa H, et al
    The incremental impact of residual SYNTAX score on long-term clinical outcomes in patients with multivessel coronary artery disease treated by percutaneous coronary interventions.
    Catheter Cardiovasc Interv. 2015;86:3-10.
    PubMed     Text format     Abstract available


  309. ZHANG L, Zhou J, Lu Q, Zhao Z, et al
    Potential risk factors of re-intervention after endovascular repair for type B aortic dissections.
    Catheter Cardiovasc Interv. 2015;86:E1-E10.
    PubMed     Text format     Abstract available


  310. ASSAD-KOTTNER C, Hakeem A, Uretsky BF
    Modified dual guide catheter ("ping-pong") technique to treat left internal mammary artery graft perforation.
    Catheter Cardiovasc Interv. 2015;86:E28-31.
    PubMed     Text format     Abstract available


  311. CHEAITO R, Benamer H, Hovasse T, Tritar A, et al
    Feasibility and safety of transradial coronary interventions using a 6.5-F sheathless guiding catheter in patients with small radial arteries.
    Catheter Cardiovasc Interv. 2015;86:51-8.
    PubMed     Text format     Abstract available


    June 2015
  312. NIJHOFF F, Agostoni P, Belkacemi A, Nathoe HM, et al
    Primary percutaneous coronary intervention by drug-eluting balloon angioplasty: The nonrandomized fourth arm of the DEB-AMI (drug-eluting balloon in ST-segment elevation myocardial infarction) trial.
    Catheter Cardiovasc Interv. 2015 Jun 29. doi: 10.1002/ccd.26060.
    PubMed     Text format     Abstract available


  313. AGARWAL S, Parashar A, Garg A, Ellis SG, et al
    Length of stay and long-term mortality following ST elevation myocardial infarction.
    Catheter Cardiovasc Interv. 2015 Jun 23. doi: 10.1002/ccd.26071.
    PubMed     Text format     Abstract available


  314. BELARDI JA, Albertal M
    Bioresorbable drug-eluting scaffold restenosis: Larger Is Probably Better.
    Catheter Cardiovasc Interv. 2015;85:1162-3.
    PubMed     Text format    


  315. COLOMBO A, Ruparelia N
    Experience and accuracy can result in parity of outcomes following one or two stents for left main stem bifurcation disease.
    Catheter Cardiovasc Interv. 2015;85:1139-40.
    PubMed     Text format    


  316. HOSHINO S, Kitano M, Abe T, Yazaki S, et al
    Efficacy and safety of percutaneous transluminal balloon dilation to prevent progression of banding site stenosis after bilateral pulmonary artery banding.
    Catheter Cardiovasc Interv. 2015;85:E197-202.
    PubMed     Text format     Abstract available


  317. GAO Z, Xu B, Yang Y, Qiao S, et al
    Comparison between one-stent versus two-stent technique for treatment of left main bifurcation lesions: A large single-center data.
    Catheter Cardiovasc Interv. 2015;85:1132-8.
    PubMed     Text format     Abstract available


  318. WIEBE J, Hamm C, Nef H
    A true bifurcational stenosis treated with a bioresorbable vascular scaffold and a drug-eluting metallic stent: Degradable meets durable.
    Catheter Cardiovasc Interv. 2015;85:1184-8.
    PubMed     Text format     Abstract available


  319. LONGO G, Granata F, Capodanno D, Ohno Y, et al
    Anatomical features and management of bioresorbable vascular scaffolds failure: A case series from the GHOST registry.
    Catheter Cardiovasc Interv. 2015;85:1150-61.
    PubMed     Text format     Abstract available


  320. SAPONTIS J, Christopoulos G, Grantham JA, Wyman RM, et al
    Procedural failure of chronic total occlusion percutaneous coronary intervention: Insights from a multicenter US registry.
    Catheter Cardiovasc Interv. 2015;85:1115-22.
    PubMed     Text format     Abstract available


  321. LEDERMAN RJ, O'Neill WW, Greenbaum AB
    Transcaval access for TAVR across a polyester aortic graft.
    Catheter Cardiovasc Interv. 2015;85:1270-3.
    PubMed     Text format     Abstract available


  322. DANSON EJ, Ward M
    Retrieval of a subintimal fractured guide wire from the brachial artery following saphenous vein graft stenting.
    Catheter Cardiovasc Interv. 2015;85:E171-4.
    PubMed     Text format     Abstract available


  323. SILVA GV, Gahremanpour A, Attizzani GF, Zeng Y, et al
    Comparison of scanning electron microscopy and optical coherence tomography for imaging of coronary bifurcation stents.
    Catheter Cardiovasc Interv. 2015;85:1141-9.
    PubMed     Text format     Abstract available


  324. NOONAN PM, Taliotis D, Alahmar A
    Percutaneous coronary intervention in a 3-year-old with hypoplastic left heart syndrome.
    Catheter Cardiovasc Interv. 2015;85:1209-11.
    PubMed     Text format     Abstract available


    May 2015
  325. BELARDI JA, Albertal M
    Being reasonable during coronary revascularization.
    Catheter Cardiovasc Interv. 2015 May 27. doi: 10.1002/ccd.26044.
    PubMed     Text format     Abstract available


  326. WILSON GJ, Marks A, Berg KJ, Eppihimer M, et al
    The SYNERGY biodegradable polymer everolimus eluting coronary stent: Porcine vascular compatibility and polymer safety study.
    Catheter Cardiovasc Interv. 2015 May 23. doi: 10.1002/ccd.25993.
    PubMed     Text format     Abstract available


  327. FINK N, Segev A, Barbash I, Bogdan A, et al
    Vascular complications in steroid treated patients undergoing transfemoral aortic valve implantation.
    Catheter Cardiovasc Interv. 2015 May 23. doi: 10.1002/ccd.26014.
    PubMed     Text format     Abstract available


  328. DAUTOV R, Abdul Jawad Altisent O, Rinfret S
    Stumpless chronic total occlusion with no retrograde option: Multidetector Computed Tomography-Guided Intervention via Bi-Radial Approach Utilizing Bioresorbable Vascular Scaffold.
    Catheter Cardiovasc Interv. 2015 May 22. doi: 10.1002/ccd.25938.
    PubMed     Text format     Abstract available


  329. CIUCA C, Tarantini G, Latib A, Gasparetto V, et al
    Trans-subclavian versus transapical access for transcatheter aortic valve implantation: A multicenter study.
    Catheter Cardiovasc Interv. 2015 May 22. doi: 10.1002/ccd.26012.
    PubMed     Text format     Abstract available


  330. BAUER T, Hochadel M, Brachmann J, Schachinger V, et al
    Use and outcome of radial versus femoral approach for primary PCI in patients with acute ST elevation myocardial infarction without cardiogenic shock: Results from the ALKK PCI registry.
    Catheter Cardiovasc Interv. 2015 May 6. doi: 10.1002/ccd.25987.
    PubMed     Text format     Abstract available


  331. CILINGIROGLU M, Marmagkiolis K
    Optimizing endovascular stroke therapy: a primary PCI deja-vu?
    Catheter Cardiovasc Interv. 2015;85:1051-2.
    PubMed     Text format    


  332. GILCHRIST IC
    Association of embolism and stroke in the catheterization laboratory.
    Catheter Cardiovasc Interv. 2015;85:1041-2.
    PubMed     Text format    


  333. HILLEGASS WB, Brott BC
    Obesity and percutaneous coronary intervention outcomes: Beware the extremes.
    Catheter Cardiovasc Interv. 2015;85:959-60.
    PubMed     Text format    


  334. DILETTI R, Garcia-Garcia HM, Bourantas C, Van Mieghem NM, et al
    Impact of body mass index on long-term clinical outcomes after second-generation drug eluting stent implantation: Insights from the international global RESOLUTE program.
    Catheter Cardiovasc Interv. 2015;85:952-8.
    PubMed     Text format     Abstract available


  335. VALVERDE I, Gomez G, Coserria JF, Suarez-Mejias C, et al
    3D printed models for planning endovascular stenting in transverse aortic arch hypoplasia.
    Catheter Cardiovasc Interv. 2015;85:1006-12.
    PubMed     Text format     Abstract available


  336. SINGH A, Kliger C, Ruiz CE
    Novel approach for the percutaneous treatment of left ventricular pseudoaneurysms.
    Catheter Cardiovasc Interv. 2015;85:1092-6.
    PubMed     Text format     Abstract available


  337. HTYTE N, Parto P, Ragbir S, Jaffe L, et al
    Predictors of outcomes following catheter-based therapy for acute stroke.
    Catheter Cardiovasc Interv. 2015;85:1043-50.
    PubMed     Text format     Abstract available


  338. VENBRUX A, Gailloud P, Radvany MG, Rudakov L, et al
    Acute, subacute, and long-term evaluation of a novel endovascular occlusion system in a large animal model.
    Catheter Cardiovasc Interv. 2015;85:1026-32.
    PubMed     Text format     Abstract available


    April 2015
  339. CONRADI L, Lubos E, Treede H, Pietzsch JB, et al
    Evolution of mitral valve procedural volumes in the advent of endovascular treatment options: Experience at an early-adopting center in Germany.
    Catheter Cardiovasc Interv. 2015 Apr 28. doi: 10.1002/ccd.25962.
    PubMed     Text format     Abstract available


  340. NAIROOZ R, Sardar P, Amin H, Chatterjee S, et al
    Short- and long-term outcomes in diabetes patients undergoing percutaneous coronary intervention with bivalirudin compared with heparin and glycoprotein IIb/IIIA inhibitors: A meta-analysis of randomized trials.
    Catheter Cardiovasc Interv. 2015 Apr 24. doi: 10.1002/ccd.25952.
    PubMed     Text format     Abstract available


  341. FERRANTE G, Valgimigli M, Pagnotta P, Presbitero P, et al
    Bivalirudin versus heparin in patients with acute myocardial infarction: A meta-analysis of randomized trials.
    Catheter Cardiovasc Interv. 2015 Apr 24. doi: 10.1002/ccd.25955.
    PubMed     Text format     Abstract available


  342. LIM W, Smith T, Rogers JH
    Transcatheter repair of aortic leaflet perforation in a patient with prior surgical bicuspid aortic valve repair.
    Catheter Cardiovasc Interv. 2015 Apr 24. doi: 10.1002/ccd.25958.
    PubMed     Text format     Abstract available


  343. ANDO G, Cortese B, Frigoli E, Gagnor A, et al
    Acute kidney injury after percutaneous coronary intervention: Rationale of the AKI-MATRIX (acute kidney injury-minimizing adverse hemorrhagic events by TRansradial access site and systemic implementation of angioX) sub-study.
    Catheter Cardiovasc Interv. 2015 Apr 9. doi: 10.1002/ccd.25932.
    PubMed     Text format     Abstract available


  344. ENG MH, Klein AJ
    The path of least resistance to success in chronic hypertension?
    Catheter Cardiovasc Interv. 2015;85:887-8.
    PubMed     Text format     Abstract available


  345. PRASAD A
    CO angiography for peripheral arterial imaging: The Good, Bad, and Ugly.
    Catheter Cardiovasc Interv. 2015;85:878-879.
    PubMed     Text format     Abstract available


  346. SCHAINFELD RM, Rajachandran M
    What's past is prologue.
    Catheter Cardiovasc Interv. 2015;85:868-9.
    PubMed     Text format     Abstract available


  347. CHANDRASEKHAR J, Mehran R
    Radial artery occlusion: preventing insult to injury.
    Catheter Cardiovasc Interv. 2015;85:826-7.
    PubMed     Text format     Abstract available


  348. HANSEN J, Gilchrist IC
    Smaller may not be better if you cut corners.
    Catheter Cardiovasc Interv. 2015;85:816-7.
    PubMed     Text format     Abstract available


  349. HILLEGASS WB, Brott BC
    Percutaneous coronary intervention: Ever closer to real world silver bullets!?
    Catheter Cardiovasc Interv. 2015;85:807-808.
    PubMed     Text format     Abstract available


  350. TRIVAX JE, Safian RD
    PCI of CTOs: hope or hype?
    Catheter Cardiovasc Interv. 2015;85:795-6.
    PubMed     Text format     Abstract available


  351. HEUSER RR
    Answer the call: let's make 2015 the year of magical thinking in CTO PCI.
    Catheter Cardiovasc Interv. 2015;85:779-80.
    PubMed     Text format     Abstract available


  352. EBRAHIM M, Hagood J, Moore J, El-Said H, et al
    Bronchoscopic guidance of endovascular stenting limits airway compression.
    Catheter Cardiovasc Interv. 2015;85:832-6.
    PubMed     Text format     Abstract available


  353. MCCROSSAN BA, Walsh KP
    Fontan fenestration closure with Amplatzer Duct Occluder II device.
    Catheter Cardiovasc Interv. 2015;85:837-41.
    PubMed     Text format     Abstract available


  354. CARLINO M, Magri CJ, Uretsky BF, Brilakis ES, et al
    Treatment of the chronic total occlusion: a call to action for the interventional community.
    Catheter Cardiovasc Interv. 2015;85:771-8.
    PubMed     Text format     Abstract available


  355. CHOI AW, Blair JE, Flaherty JD
    Abciximab-induced alveolar hemorrhage treated with rescue extracorporeal membranous oxygenation.
    Catheter Cardiovasc Interv. 2015;85:828-31.
    PubMed     Text format     Abstract available


  356. FORAN JP, Jain AK, Casserly IP, Kandzari DE, et al
    The ROX coupler: creation of a fixed iliac arteriovenous anastomosis for the treatment of uncontrolled systemic arterial hypertension, exploiting the physical properties of the arterial vasculature.
    Catheter Cardiovasc Interv. 2015;85:880-6.
    PubMed     Text format     Abstract available


  357. KHAN MF, Brilakis ES, Wendel CS, Thai H, et al
    Comparison of procedural complications and in-hospital clinical outcomes between patients with successful and failed percutaneous intervention of coronary chronic total occlusions: a meta-analysis of observational studies.
    Catheter Cardiovasc Interv. 2015;85:781-94.
    PubMed     Text format     Abstract available


  358. ABOU ZAHR R, Hellenbrand WE, Asnes JD
    Iatrogenic left pulmonary artery to left atrium fistula.
    Catheter Cardiovasc Interv. 2015;85:847-9.
    PubMed     Text format     Abstract available


  359. KUO JA
    Percutaneous device occlusion of hepatocardiac venous collateral via left transhepatic access in a patient with heterotaxy syndrome following Fontan procedure.
    Catheter Cardiovasc Interv. 2015;85:E140-3.
    PubMed     Text format     Abstract available


  360. SHACKLES C, Rundback JH, Herman K, David Y, et al
    Above and below knee femoropopliteal VIABAHN(R).
    Catheter Cardiovasc Interv. 2015;85:859-67.
    PubMed     Text format     Abstract available


  361. DHARMA S, Kedev S, Patel T, Kiemeneij F, et al
    A novel approach to reduce radial artery occlusion after transradial catheterization: postprocedural/prehemostasis intra-arterial nitroglycerin.
    Catheter Cardiovasc Interv. 2015;85:818-25.
    PubMed     Text format     Abstract available


    March 2015
  362. ABTAHIAN F, Waldo S, Jang IK
    Comparison of heparin and bivalirudin in patients undergoing percutaneous coronary intervention without use of glycoprotein IIb/IIIa inhibitors.
    Catheter Cardiovasc Interv. 2015 Mar 7. doi: 10.1002/ccd.25911.
    PubMed     Text format     Abstract available


  363. AMOROSO G, Vos NS, Van der Heyden JA, van der Schaaf RJ, et al
    A prospective, post-market study with the MGuard prime embolic protection stent in ST-segment elevation myocardial infarction: The international mguard prime observational study (IMOS Prime).
    Catheter Cardiovasc Interv. 2015 Mar 7. doi: 10.1002/ccd.25914.
    PubMed     Text format     Abstract available


  364. LODI-JUNQUEIRA L, da Silva JL, Ferreira LR, Goncalves HL, et al
    In-hospital mortality risk prediction after percutaneous coronary interventions: validating and updating the Toronto score in Brazil.
    Catheter Cardiovasc Interv. 2015 Mar 7. doi: 10.1002/ccd.25916.
    PubMed     Text format     Abstract available


  365. ASHIKAGA T, Yoshikawa S, Isobe M
    The effectiveness of excimer laser coronary atherectomy with contrast medium for under-expanded stent; The findings of optical frequency domain imaging.
    Catheter Cardiovasc Interv. 2015 Mar 7. doi: 10.1002/ccd.25915.
    PubMed     Text format     Abstract available


  366. KOBAYASHI Y, Tremmel JA
    The relationship between fractional flow reserve and index of microcirculatory resistance: be careful with whom you associate.
    Catheter Cardiovasc Interv. 2015;85:593-4.
    PubMed     Text format    


  367. TOPAZ O
    Inhibition of thrombus formation inside the stent during PCI.
    Catheter Cardiovasc Interv. 2015;85:583-4.
    PubMed     Text format    


  368. GOLDSTEIN JA, Dixon SR
    In-stent neoatherosclerosis and distal embolization: lesion architecture, composition, and PCI compression.
    Catheter Cardiovasc Interv. 2015;85:573-4.
    PubMed     Text format    


  369. VETROVEC GW
    Another challenge for the presumed safety advantage of bare metal stents: noncardiac surgery.
    Catheter Cardiovasc Interv. 2015;85:542-3.
    PubMed     Text format    


  370. BUTMAN S
    Generations: the old gives way to the new, and the new is too soon the old.
    Catheter Cardiovasc Interv. 2015;85:532.
    PubMed     Text format    


  371. GILCHRIST IC
    Vignettes of DES failure.
    Catheter Cardiovasc Interv. 2015;85:522-3.
    PubMed     Text format    


  372. ROMAGUERA R, Brugaletta S, Gomez-Lara J, Pinar E, et al
    Rationale and study design of the RESERVOIR trial: a randomized trial comparing reservoir-based polymer-free amphilimus-eluting stents versus everolimus-eluting stents with durable polymer in patients with diabetes mellitus.
    Catheter Cardiovasc Interv. 2015;85:E116-22.
    PubMed     Text format     Abstract available


  373. VEERAM REDDY SR, Welch TR, Wang J, Richardson JA, et al
    A novel design biodegradable stent for use in congenital heart disease: mid-term results in rabbit descending aorta.
    Catheter Cardiovasc Interv. 2015;85:629-39.
    PubMed     Text format     Abstract available


  374. ATTIZZANI GF, Ohno Y, Capodanno D, Francaviglia B, et al
    New insights on acute expansion and longitudinal elongation of bioresorbable vascular scaffolds in vivo and at bench test: a note of caution on reliance to compliance charts and nominal length.
    Catheter Cardiovasc Interv. 2015;85:E99-E107.
    PubMed     Text format     Abstract available


  375. VERGALLO R, Joye R, Barlis P, Jia H, et al
    Bivalirudin versus unfractionated heparin for residual thrombus burden: a frequency-domain optical coherence tomography study.
    Catheter Cardiovasc Interv. 2015;85:575-82.
    PubMed     Text format     Abstract available


    February 2015
  376. CRIMI G, Leonardi S, Costa F, Ariotti S, et al
    Incidence, prognostic impact, and optimal definition of contrast-induced acute kidney injury in consecutive patients with stable or unstable coronary artery disease undergoing percutaneous coronary intervention. insights from the all-comer PRODIGY tri
    Catheter Cardiovasc Interv. 2015 Feb 20. doi: 10.1002/ccd.25822.
    PubMed     Text format     Abstract available


  377. RANEY AR, Stinis CT
    Use of intravascular ultrasound to guide endovascular repair of popliteal artery aneurysms.
    Catheter Cardiovasc Interv. 2015 Feb 12. doi: 10.1002/ccd.25893.
    PubMed     Text format     Abstract available


  378. URBAN P, Valdes M, Menown I, Eberli F, et al
    Outcomes following implantation of the Biolimus A9-eluting BioMatrix coronary stent: Primary analysis of the e-BioMatrix registry.
    Catheter Cardiovasc Interv. 2015 Feb 12. doi: 10.1002/ccd.25892.
    PubMed     Text format     Abstract available


  379. ANDERSON SG, Ratib K, Myint PK, Keavney B, et al
    Impact of age on access site related outcomes in 469,983 percutaneous coronary intervention procedures; insights from the British Cardiovascular Intervention Society.
    Catheter Cardiovasc Interv. 2015 Feb 11. doi: 10.1002/ccd.25896.
    PubMed     Text format     Abstract available


    January 2015
  380. MAENG M, Baranauskas A, Christiansen EH, Kaltoft A, et al
    10-month angiographic and 4-year clinical outcome of everolimus-eluting versus sirolimus-eluting coronary stents in patients with diabetes mellitus (the DiabeDES IV randomized angiography trial).
    Catheter Cardiovasc Interv. 2015 Jan 30. doi: 10.1002/ccd.25875.
    PubMed     Text format     Abstract available


  381. SINGH M, Mishra A, Kaluski E
    Acute ST-Elevation Myocardial Infarction due to Septic Embolism: A Case Report and Review of Management Options.
    Catheter Cardiovasc Interv. 2015 Jan 9. doi: 10.1002/ccd.25829.
    PubMed     Text format     Abstract available


    December 2014
  382. CHAN YH, Stella PR, Agostoni P
    A "simplified" culotte technique using two dedicated bifurcation stents and additional angiographic stent enhancement to treat a complex bifurcation lesion in non-ST segment elevation myocardial infarction with poor left ventricular function.
    Catheter Cardiovasc Interv. 2014 Dec 22. doi: 10.1002/ccd.25795.
    PubMed     Text format     Abstract available


  383. ELLING R, Stiller B, Grohmann J
    Transcatheter device occlusion of the left ventricular outflow tract as treatment for severe aortic regurgitation in hypoplastic left heart syndrome.
    Catheter Cardiovasc Interv. 2014 Dec 22. doi: 10.1002/ccd.25782.
    PubMed     Text format     Abstract available


    November 2014
  384. KWOK CS, Anderson SG, McAllister KS, Sperrin M, et al
    Impact of age on the prognostic value of left ventricular function in relation to procedural outcomes following percutaneous coronary intervention; insights from the British Cardiovascular Intervention Society.
    Catheter Cardiovasc Interv. 2014 Nov 19. doi: 10.1002/ccd.25732.
    PubMed     Text format     Abstract available


  385. ROSSINI R, Oltrona Visconti L, Musumeci G, Filippi A, et al
    A multidisciplinary consensus document on follow-up strategies for patients treated with percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2014 Nov 7. doi: 10.1002/ccd.25724.
    PubMed     Text format     Abstract available


  386. FUJIHARA M, Kawasaki D, Shintani Y, Fukunaga M, et al
    Endovascular therapy by CO angiography to prevent contrast-induced nephropathy in patients with chronic kidney disease: A prospective multicenter trial of CO angiography registry.
    Catheter Cardiovasc Interv. 2014 Nov 7. doi: 10.1002/ccd.25722.
    PubMed     Text format     Abstract available


  387. BALDERSTON JR, Giri J, Kolansky DM, Bavaria JE, et al
    Coronary artery aneurysms associated with ascending aortic aneurysms and abdominal aortic aneurysms: Pathophysiologic implications.
    Catheter Cardiovasc Interv. 2014 Nov 7. doi: 10.1002/ccd.25726.
    PubMed     Text format     Abstract available


    October 2014
  388. ABDELAAL E, Rimac G, Plourde G, MacHaalany J, et al
    4Fr in 5Fr sheathless technique with standard catheters for transradial coronary interventions: Technical challenges and persisting issues.
    Catheter Cardiovasc Interv. 2014 Oct 20. doi: 10.1002/ccd.25709.
    PubMed     Text format     Abstract available


    September 2014
  389. VIGNALI L, Saia F, Belotti LM, Solinas E, et al
    New- generation drug-eluting stents reduce stent thrombosis and myocardial infarction: A propensity-score-adjusted analysis from the multicenter REAL registry (REgistro Regionale AngiopLastiche dell'Emilia-Romagna).
    Catheter Cardiovasc Interv. 2014 Sep 25. doi: 10.1002/ccd.25675.
    PubMed     Text format     Abstract available


  390. HOFFMAN SJ, Yee AH, Slusser JP, Rihal CS, et al
    Neuroimaging patterns of ischemic stroke after percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2014 Sep 25. doi: 10.1002/ccd.25678.
    PubMed     Text format     Abstract available


    August 2014
  391. LEE SY, Hong MK, Shin DH, Kim JS, et al
    Optical coherence tomography-based predictors for creatine kinase-myocardial band elevation after elective percutaneous coronary intervention for in-stent restenosis.
    Catheter Cardiovasc Interv. 2014 Aug 26. doi: 10.1002/ccd.25643.
    PubMed     Text format     Abstract available


  392. FREIXA X, Chan J, Bonan R, Ibrahim R, et al
    Impact of coronary artery disease on left ventricular ejection fraction recovery following transcatheter aortic valve implantation.
    Catheter Cardiovasc Interv. 2014 Aug 12. doi: 10.1002/ccd.25632.
    PubMed     Text format     Abstract available


    July 2014
  393. DE BACKER O, Lonn L, Sondergaard L
    Combined surgical and catheter-based treatment of extensive thoracic aortic aneurysm and aortic valve stenosis.
    Catheter Cardiovasc Interv. 2014 Jul 2. doi: 10.1002/ccd.25592.
    PubMed     Text format     Abstract available


    January 2014
  394. SPIRO J, Venugopal V, Raja Y, Ludman PF, et al
    Feasibility and efficacy of the 2.5L and 3.8L Impella percutaneous left ventricular support device during high-risk, percutaneous coronary intervention in patients with severe aortic stenosis.
    Catheter Cardiovasc Interv. 2014 Jan 9. doi: 10.1002/ccd.25355.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Vascular Surgery is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: